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ABSTRACT 
 
Erik Albert Karlsson 
 
THE INFLUENCE OF DIET-INDUCED OBESITY ON THE GENERATION, FUNCTION 
AND MAINTENANCE OF INFLUENZA-SPECIFIC MEMORY CD8+ T CELLS 
(Under the direction of Melinda A. Beck, Ph.D.) 
 
 
In both humans and animal models, obesity leads to a dysregulated immune 
response; however, the effect of obesity on response to viral infection is largely 
unknown. Yearly outbreaks of influenza virus are a major cause of morbidity and 
mortality and obesity may increase this risk. Indeed, when challenged with influenza 
virus, obese mice exhibit a decreased immune response to influenza infection leading to 
increased morbidity and mortality. Memory CD8+ T cells generated during primary 
influenza infection target internal proteins common among influenza viruses, making 
them effective against encounters with heterologous strains. Since previous studies in 
our laboratory have shown that diet-induced obese mice have a significantly altered 
primary immune response to influenza infection, we hypothesized that obese mice would 
have an impaired memory CD8+ T cell response to secondary influenza infection. In 
male, diet-induced obese C57Bl/6 mice, a secondary H1N1 influenza challenge following 
a primary H3N2 infection led to a 25% mortality rate (with no loss of lean controls), 25% 
increase in lung pathology, failure to regain weight and 10 to 100 fold higher lung viral 
titers. Furthermore, mRNA expression for interferon γ (IFN-γ) was >60% less in lungs of 
obese mice along with one third the number influenza-specific CD8+ T cells producing 
IFN-γ post secondary infection versus lean controls. Memory CD8+ T cells from obese 
mice had a >50% reduction in IFN-γ production when stimulated with influenza-pulsed 
dendritic cells from lean mice. In addition, maintenance of influenza-specific memory T 
 iv
cells was impaired in obese mice with a 10% reduction in this population 84 days post 
primary infection. Thus, the function and maintenance of influenza-specific memory T 
cells is significantly reduced and ineffective in lungs of obese mice. The reality of a 
worldwide obesity epidemic combined with yearly influenza outbreaks and the current 
threat of an H1N1 pandemic makes it imperative to understand how influenza virus 
infection behaves differently in an obese host. Moreover, impairment of memory 
responses has significant implications for vaccine efficacy in an obese population. 
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CHAPTER I 
 
BACKGROUND AND SIGNFICANCE 
 
A. Specific Aims 
In both humans and animal models, obesity leads to a dysregulated immune 
response. Deleterious changes in the immune function of obese subjects have been 
described such as increased susceptibility to infection, decreased ability to produce 
beneficial immune cytokines and lowered numbers of immune specific cells and subsequent 
cellular responses. Because of these associated problems with the immune system, one 
would expect a large body of data on the consequences of viral challenge during the obese 
state; however, the effect of obesity on response to viral infection is largely unknown. To 
understand how obesity could affect the immune response to viral infection, influenza virus 
infection was used as a model. Yearly outbreaks of influenza virus are a major cause of 
morbidity and mortality and obesity may increase this risk. Indeed, when challenged with 
influenza virus, obese mice exhibit a decreased immune response to influenza infection 
leading to increased morbidity and mortality, yet the exact mechanisms that cause this 
altered response have yet to be elucidated.  
Effective clearance of the influenza virus is dependent on both innate and adaptive 
immune mechanisms. Diet-induced obese mice challenged with influenza virus exhibit 
increased lung pathology, decreased antiviral cytokine response, delayed expression of 
beneficial inflammatory cytokines and chemokines as well as increased influenza-specific 
CD8+ T cells. Primary infection with influenza virus leads to the generation and maintenance 
2 
 
of a pool of protective memory CD8+ T cells which can more rapidly respond to a secondary 
encounter. The initial primary response to infection as well as lung microenvironmental 
conditions can have a major impact on memory T cell generation and functionality. Since 
previous studies in our laboratory have shown that diet-induced obese mice have a 
significantly altered primary immune response to influenza infection, we hypothesized that 
obese mice would have an impaired memory CD8+ T cell response to secondary 
influenza infection. 
 
Specific Aims 
1. To determine if diet-induced obesity in mice alters the CD8+ T cell memory response 
(recall response) to a second infection with influenza virus  
2. To determine if diet-induced obesity in mice affects the maintenance of influenza antigen-
specific memory CD8+ T cell subpopulations  
3. To determine if diet-induced obesity in mice affects the generation of influenza-specific 
CD8+ memory T cells during a primary influenza infection 
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B. Obesity: Definition and Public Health Perspective 
Obesity has become a worldwide epidemic. In 2005, the World Health Organization 
(WHO) projected that approximately 1.6 billion adults were overweight (Body Mass Index, 
BMI ≥25), and at least 400 million of these adults were clinically obese (BMI ≥30). 
Furthermore, the WHO predicts that by the year 2015, approximately 2.3 billion adults will be 
overweight with greater than 700 million of these adults being obese (1). In the United 
States (US) alone, the National Health and Nutrition Examination Survey (NHANES) 
predicted that over 66% of the population was overweight or obese (2). Recent projections 
based on NHANES predict that if the current trends continue, more than half (51.1%) of US 
adults are likely to be obese and 86.3% are likely to be overweight or obese by 2030 (3). 
Analysis of obesity trends by Hill et al. in 2003, suggested that the obesity epidemic has 
arisen from gradual yearly weight gain in the population produced from a slight consistent 
degree of positive energy balance. Their findings indicate that the average adult in the 
United States has gained an average of 1 to 2 lb/y for the past 2 to 3 decades (2,4). 
Obesity has traditionally been considered a problem affecting adults in high-income 
countries; however, obesity rates are also rising rapidly in low- to middle-income countries, 
especially in urban settings. Childhood obesity is also on the rise. Globally in 2005, there 
were more than 20 million overweight children under the age of 5 (1).  In addition to a large 
portion of the population being overweight, it appears that incidence of clinically severe 
obesity (BMI ≥40) is growing at an exponential rate. Based on data from the Behavioral Risk 
Factor Surveillance System (BRFSS), between 1986 and 2000, prevalence of obesity (BMI 
≥30) doubled from 1 in 10 US adults to 1 in 5. However, when focused in on clinically severe 
obesity, prevalence of BMI ≥40 quadrupled from about 1 in 200 US adults to 1 in 50 and 
prevalence of BMI ≥50 increased from 1 in 2000 to 1 in 400, a five fold increase. Therefore,
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TABLE 1.1: BMI RANGES 
 BMI RANGE 
STARVATION <15 
UNDERWEIGHT <18 
NORMAL 18-24.9 
OVERWEIGHT 25-29.9 
OBESE 30-39.9 
MORBID OBESITY >40 
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obesity is not only increasing in the US, prevalence of super obese individuals is also 
increasing at an alarming rate (5). Recently, a study by Flegal et al. (2010) have reported 
that the prevalence of obesity in the US may be leveling off according to the most recent 
sets of NHANES data. However, according to the 2007-2008 NHANES data, 68.0% of the 
US population still has a BMI ≥ 25 meaning that 2 out of every 3 people are overweight or 
obese (6). Therefore, even if the prevalence of obesity is leveling in the US a significant 
portion of the population is still at risk for the comorbidities associated with obesity. In 
addition, rates of obesity are increasing worldwide, not just in the American population. 
Although humans, as a species, are relatively well adapted to periods of lean food 
intake, they are poorly adapted to overnutrition. Human biology, which has evolved in times 
of frequent famine, is now for all intents and purposes maladaptive in our calorie-rich, 
sedentary environment (7,8). The obese state can lead to serious health consequences and 
subsequently, increases in health care requirements and economic burden. Caused by a 
change in energy balance of increased caloric intake versus expenditure (9), obesity has 
been linked to numerous health problems and chronic diseases (10-12). These 
comorbidities associated with obesity have been attributed with hormonal and metabolic 
changes related to increased adipose tissue mass (13-15). Obesity is an independent risk 
factor for cardiovascular disease (CVD), type 2 diabetes (T2D), hypertension, arthritis, sleep 
apnea and some cancers. Obese individuals are at increased risk for high blood pressure 
and unfavorable blood lipid profiles which can lead to CVD. Obesity can also be directly 
related to CVD apart from blood pressure and lipid levels (16,17). Individuals with a BMI ≥30 
have a 60- to 80-fold increased risk of developing T2D; however, this huge increase in risk 
may be due to an intrinsic relationship between obesity and T2D termed “diabesity” (18). 
Indeed, in the Diabetes Prevention Program, weight loss of 5 to 6% along with increased 
physical activity in persons with a BMI of 34 kg/m2 resulted in a 58% reduction in the 
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incidence of diabetes (19). In regards to cancer, Calle et. al. (2003) and others have 
reported that increased body weight is associated with increased death rates for all cancers 
combined and for cancers at multiple specific sites (20).  Obesity also has been found to 
have adverse effects on the respiratory system including alteration in respiratory mechanics 
and pulmonary function tests. Most commonly these complaints are evident with shortness 
of breath during periods of exertion (17,21). Aside from all of the comorbidities, obesity can 
be directly related to a reduction of lifespan and a premature risk of death. High BMI levels 
are risk factors for all cause mortality. In addition, increased BMI was directly related to 
increased mortality risk in both the Nurses’ Health Study and the US Health Professionals 
Follow-Up Study (22-26). Based on all of the relative risks, Oster et al. (1999) calculated that 
a weight loss of 10% in obese individuals could increase life expectancy by 27 months 
(27,28). 
In addition to the health problems, chronic diseases and reduction of lifespan, obese 
individuals also face other challenges in the health care system. Many physician offices and 
hospitals are not equipped to take care of severely obese individuals. Obese patients may 
not fit in standard medical equipment such as imaging scanners, hospital beds or even 
wheelchairs. Additionally, the lack of the ability to weigh individuals over 300 lbs in 
ambulatory settings could affect the quality of care given to obese patients (5).  It is also 
important to note that the increasing prevalence of obesity can translate directly into 
increased medical care and disability costs. Obese adults incur annual medical expenditures 
which are approximately 36% higher than normal weight individuals (29,30). This increase 
can be further divided into BMI classes, resulting in a BMI ≥40 having double (~100% 
greater) the healthcare costs of a normal weight individual (31). In 1998, approximately 
5.7% ($51.6 billion) of the total health care expenditures in the United States could be 
attributable to direct medical costs associated with obesity and its cormorbidities. 
Additionally, obesity has indirect costs attributable to loss of work caused by morbidity and 
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mortality and can be estimated at $47.6 billion annually but may be even more impactful 
than direct costs at the personal and societal levels (32). In 1999, Colditz reported that the 
costs of obesity were estimated to be 7% of the total health care costs in the US and 
between 1% to 5% in Europe (33,34). In 2002, the annual medical spending attributable to 
overweight and obesity was estimated at 9.1% of total health care costs (30). Although the 
increased costs of obesity are generally attributed to its associated comorbidities such as 
T2D and CVD, impaired immunity in obese individuals may also contribute to this increased 
cost. 
 
C. Animal Models of Obesity 
 
The use of animal models has been and will be the cornerstone of our understanding of 
obesity and its effects on physiology including the immune system. Since many studies, 
especially those involving infectious pathogens and experimental analysis of vital organs, 
cannot be conducted in human populations, mouse models of obesity have been generated 
to study the physiological and biochemical effects of obesity. The use of animal models to 
study phenomenon that underlie obesity or result as a consequence of obesity has provided 
an enormous amount of information that impacts our understanding of the obese state. 
While these models provide a good starting point for understanding the deleterious effects of 
obesity, it must be recognized that animal models may not be directly comparable to human 
populations and studies still need to be conducted in obese individuals (35).  
 
C.1 Genetic Models of Rodent Obesity  
 
Energy homeostasis is a very complex, long-term process comprised of multiple 
interacting homeostatic and behavioral pathways, including glucose and lipid homeostasis, 
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the hypothalamic-pituitary-adrenal axis and satiety as well as other macronutrient pathways 
that all act in concert to maintain constant levels of energy stores (36) A small number of 
energy balance genes are known to be essential for normal body-weight regulation, with 
loss of function mutations in a single gene leading to obesity in laboratory animal models 
and in small, rare populations of human subjects (37). Discovery of these models can be 
attributed to astute colony managers noticing abnormal obesity phenotypes and then 
selectively to bring forth these traits in homozygotes (38). Historically, five such mutations 
(agouti, fat, tubby, obese and diabetes) were identified and a number of transgenic and 
knockout models of obesity and other body weight regulatory conditions have been created 
(39-42). It is now clear that any disruption in the development, differentiation or metabolism 
of the adipocyte can cause obesity or obesity resistance (36,43,44). Obesity itself is a highly 
complex trait and polygenic mouse models of obesity such as recombinant inbred lines, 
long-term selection lines and heterogeneous stocks are beginning to be studied intensely 
using newer and more powerful gene discovery tools (45).  
 
C.2 Diet-induced Models of Rodent Obesity 
 
Loss-of-function mutations, whether they be single genes or polygenic, reveal their 
products to be essential for normal body weight regulation in mammals. While these models 
are essential for basic scientific discovery, the occurrence of these mutations in human 
populations is extremely rare and does not help to elucidate the cause and/or effects of 
obesity in the majority of humans (46,47). Generally, it is assumed that most obesity is a 
result of small changes in a number of genes subjected to an obesigenic environment (diet, 
physical activity, built environment, socio-economic status, etc). Thus, since current 
lifestyles have reduced physical activity in conjunction with easy access to palatable and 
energy dense diets, it can be hypothesized that diet can be the major contributor to the 
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majority of human obesity. Therefore, it would be beneficial to incorporate diet-induced 
obesity (DIO) into the design of studies in laboratory rodents and, in fact, DIO models are 
beginning to be employed more and more in the laboratory setting. It must be noted, 
however, that the dietary manipulations performed need to be carefully considered to 
determine the most appropriate diet to model common human obesity. 
There is wide variation in the types of diets used to induce obesity. Generally, DIO is 
achieved using the incorporation of increased dietary fats into the diet. However, the amount 
of fat can vary between 20% to 60% of energy. Adding further complexity, the fat 
macronutrient itself may be derived from either animal or plant products such as lard or 
coconut oil. DIO models include rodent, canine and other species and, within those species, 
a number of different strains (48,49). Several mouse strains have been described in the 
literature, including those by Surwit et al. (1988), West et al. (1992), and Reifsnyder et al. 
(2000), in which susceptibility to obesity has been found to be strain dependent. For 
example, some strains of mice (eg: C57BL/6) are more susceptible to DIO while other 
strains (eg: SWR/J) appear to be resistant (50-52). Moreover, these susceptibility and 
resistance dynamics can be affected by the dietary components (53). Even when specific 
strain/diet combinations are used, duration of dietary exposure, such as 4 months versus 6 
months of treatment, could provide variability in level of obesity and its effect on outcome. 
Overall, the objective of DIO models is to mimic the palatability-driven over-consumption that 
exemplifies the majority of human obesity. Because of the extreme variability in all aspects 
of DIO induction, it is important that studies that use DIO models are only compared to 
experiments utilizing similar, if not exactly equivalent, dietary study designs (49). 
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C.3 Non-traditional Models of Obesity 
 
In addition to more traditional rodent models of obesity, there are several studies 
which look at other obese systems such as seasonal models, companion animals, exotic 
models and non-human primates (38). Many small mammals exhibit annual cycles of 
reproduction that are accompanied by variations in body mass and adiposity. Hamsters, 
voles, lemmings and squirrels have all been studied for seasonal changes in adiposity 
mainly by linking them to photoperiod-triggered changes in leptin signaling (54,55). 
Hamsters have also been shown to be highly susceptible to obesigenic dietary treatment 
(56). Companion animals such as dogs and cats have also been noted to become obese 
when fed higher levels of dietary fat (57). Interestingly, the magnitude of this effect may be 
strain dependent which indicates an underlying genetic component in some strains (58).  
Other studies involve more exotic models, usually involving wild species which 
undergo natural patterns of variability in their fat mass such as seals and bats (59,60). 
Several models of spontaneous obesity have also been noted in nonhuman primates, most 
notably macaque and rhesus monkeys (58,61). Additionally, controlled dietary studies in 
primate models have observed the association of high-fat diets with body composition (58).  
 
D. Obesity as a Modulator of Immune Function 
 
Obesity is well established as a risk factor for increased morbidity and mortality; 
however, its effects on susceptibility to infection are just beginning to be understood. 
Conventionally, obesity can be considered an overaccumulation of white adipose tissue 
(WAT). Although adipocytes occupy the bulk of the volume of WAT, adipose tissue also 
includes many more cells types. Nonadipocytic cells in WAT consist of a diverse population 
of preadipocytes, macrophages, endothelial cells, fibroblasts and leukocytes (62). WAT is 
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now considered an important part of body regulation and can act as an endocrine organ, 
secreting numerous factors, which can affect several metabolic pathways and even the 
function of the immune system.  
 
D.1 Adipokines  (Table 1.2) 
 
In the past two decades, research has pushed the concept of WAT as an endocrine 
organ in its own right versus just serving as a storage depot for fats. Indeed, WAT has been 
found to produce close to 100 cytokines and other molecules including leptin, adiponectin, 
resistin, visfatin, apelin, vaspin, hepcidine, TNF-α, omentin and monocyte chemoattractant 
protein 1 (MCP-1). These “adipokines” participate in a wide variety of physiological or 
pysiopathological processes including food intake, insulin sensitivity and inflammation. In 
addition, many of the adipokines have been found to play an intricate role in various aspects 
of the innate and adaptive immune response (63-66). Obesity was the original condition 
which motivated the study of WAT. In the obese state, secretion of these adipokines is 
altered in correlation to the increased adipose tissue mass (14,67-69). For example, 
secretion of leptin, interleukin (IL)-6 and tumor necrosis factor alpha (TNFα) are all 
increased in obese individuals while adiponectin secretion is decreased. Adding to this 
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TABLE 1.2: ADIPOKINES IN OBESITY AND THEIR EFFECT ON THE IMMUNE SYSTEM 
 
FACTOR METABOLIC EFFECT IMMUNE EFFECT DURING OBESITY REFS 
ADIPONECTIN 
↓ GLUCONEOGENESIS 
↑ GLUCOSE UPTAKE  
Β-OXIDATION 
INSULIN SENSITIVITY 
WEIGHT LOSS 
ENERGY METABOLISM 
ANTI-INFLAMMATORY 
↓ T CELL RESPONSES 
↓ B CELL 
LYMPHOPOESIS 
REDUCED (62,66,70,71) 
LEPTIN 
↑LIPOLYSIS 
↓ FOOD INTAKE 
 
INFLAMMATORY 
↑ T CELL 
PROLIFERATION 
↑ LYMPHOPOESIS 
↑ THYMOCYTE 
SURVIVAL 
↑ TH1 RESPONSE 
INCREASED (SIGNAL 
REDUCED) 
(72-77) 
VISFATIN/PBEF 
↑INSULIN SENSITIVITY INFLAMMATORY 
 
INCREASED (14,62,63) 
RESISTIN DIABETOGENIC INFLAMMATORY INCREASED (78) 
CHEMERIN 
↑ LIPOLYSIS 
ADIPOCYTE 
DIFFERENTIATION CHEMOATTRACTANT INCREASED 
(62,79) 
APELIN 
↑ INSULIN SENSITIVITY 
↓INSULIN SECRETION  INCREASED 
(80) 
OMENTIN  ANTI-INFLAMMATORY REDUCED  
VASPIN ↑ INSULIN SENSITIVITY  INCREASED (81) 
ADIPSIN ↓ TAG PRODUCTION 
COMPLEMENT 
ACTIVIATION INCREASED 
 
HEPCIDINE IRON HOMEOSTASIS 
↓ IRON RELEASE 
FROM MACROPHAGES INCREASED 
(82) 
GLUCOSE (HIGH) ↑ INSULIN  INFLAMMATORY 
   
INCREASED (83,84) 
INSULIN ↑ GLUCOSE UPTAKE 
↓ FOOD INTAKE 
↓ LYPOLYSIS 
INFLAMMATION INCREASED (SIGNAL 
REDUCED) 
(85) 
IL-6 ↓ INSULIN SENSITIVITY 
↑ LIPOLYSIS 
INFLAMMATORY INCREASED (86) 
TNFα ↓ INSULIN SENSITIVITY 
↑ LIPOLYSIS 
INFLAMMATORY INCREASED (87) 
MCP-1  CHEMOATTRACTANT INCREASED (62,88) 
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complexity is the heterogeneity of the secretory profiles of each adipose tissue. Different fat 
depots in the body play distinct roles and secrete different sets of cytokines with visceral 
adipose tissue considered to be the most detrimental in the obesigenic state. For example, 
visceral adipose tissue has been found to release more resistin, TNFα and IL-6 per gram of 
tissue than does abdominal subcutaneous adipose tissue (62,69,89,90).  
The heterogeneous composition and secretory profile of WAT, especially visceral 
WAT, is considered an important mediator of metabolism and inflammation (62). A low-
grade state of inflammation has been associated with obesity. Although not completely 
demonstrated, the current working hypothesis is that adipokines, cytokines and other factors 
produced and released by WAT in obese states such as IL-6, TNFα and C-reactive protein 
(CRP) are responsible for this chronic inflammation (14,91). The presence of this low-grade, 
systemic chronic inflammation has been linked to the increased risk of development of CVD 
and T2D in obesity, being especially associated with visceral adiposity. As stated above, 
WAT is composed of a number of different cell types apart from adipocytes, including 
immune cells such as macrophages. The number of macrophages present in WAT is directly 
correlated to adiposity and adipocyte size in both obese animals and human subjects (92-
94). As adipose size increases with obesity, adipocyte size increases accompanied by an 
influx of macrophages and other immune cells. The circulating levels of TNFα and IL-6 seen 
in obese subjects are considered to come from these macrophages since macrophages are 
considered to be the major source of TNFα from WAT and 50% of WAT-derived IL-6 
(93,95).   
 Based on WATs function as an endocrine organ and its ability to influence 
inflammatory processes within the body, it is not surprising that local, obesity-driven 
changes in adipokine secretion have a systemic impact on several branches of the immune 
system. One adipokine that has been shown to have particular immunomodulatory 
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properties is leptin. Leptin and leptin-associated signaling pathways may provide a direct 
link between obesity and immune function.  
 
D.2 Leptin 
 
In the late 1950’s a genetic defect that caused severe obesity due to overeating and 
decreased energy expenditure was identified in a population of mice (96). The gene was 
named obese (ob) and obese mice carrying the mutation were identified as ob/ob (97). The 
discovery of leptin, which is produced by adipocytes, in 1994 by Friedman and colleagues 
as the molecular defect for the ob/ob phenotype (98) prompted the paradigm shift that WAT 
was truly an endocrine organ in itself.  Leptin is a 16 kDa anorexic peptide that functions 
primarily in the hypothalamus to decrease food intake and increase energy expenditure 
(98,99). Initially, the effects of leptin were thought to be only centrally mediated; however, 
the functional pleiotropy that leptin shares with other members of the long-chain helical 
cytokine family have shown it to be capable of stimulating a variety of biological responses 
in a wide spectrum of cell types.  Leptin levels can be proportional to insulin levels and 
inversely proportional to glucocorticoid concentrations (77,100,101). Leptin synthesis is 
regulated by food intake and eating-related hormones, but it also depends on energy status, 
sex hormones and a wide range of inflammatory mediators (102,103). In accordance, leptin 
synthesis is increased following acute infection or sepsis.  
 
D.2.1. Leptin Control of Food Intake (Figure 1.1) 
 
The early studies of leptin focused on its anorexigenic action. Leptin levels act as a 
general signal of energy reserves and to modulate food intake and, therefore, leptin 
concentrations increase proportionately to adipose mass (and BMI) that results in high  
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FIGURE 1.1: LEPTIN CONTROL OF FOOD INTAKE 
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circulating levels in obese individuals (104-108).  Defects in the genes encoding leptin and 
its receptors give rise to severe obesity and diabetes. Leptin acts to control food intake by 
acting on an intricate neuronal circuit involving hypothalamic and brainstem nuclei where it 
integrates a variety of different orexigenic and anorexigenic signals (109). 
 Leptin receptors are found in the highest levels in the neurons of several nuclei of the 
hypothalamus, especially in the arcuate (ARC) nuclei (110,111). In the ARC, leptin 
stimulates the production of pro-opiomelanocortin (POMC) that is then processed to 
produce α-melanocyte-stimulating hormone (αMSH) in neurons, which signals anorexia by 
activating the melanocortin-4 receptor (MC4R). In contrast, another population of ARC 
neurons synthesizes neuropeptide Y (NPY), an orexigenic hormone, and agouti-related 
peptide (AgRP) which is an antagonist of αMSH/MC4R signaling. Leptin acts via its receptor 
to inhibit these NPY/AgRP neurons and to suppress the expression of these neuropeptides. 
Therefore, leptin stimulation in the ARC results in the production of anorectic neuropeptides 
and suppresses levels of orexigenic peptides. Conversely, decreased leptin activity (e.g.: 
during starvation) stimulates appetite by suppressing synthesis of anorectic neuropeptides 
(POMC) and increasing orexigenic peptides (NPY and AgRP) (112-116) (Figure 1.1). 
 
D.2.2. Leptin Receptors and Signaling (Figure 1.2) 
 
Leptin exerts its biological actions by binding to its receptor. The leptin receptor (Ob-
R) was identified shortly after the discovery of leptin itself (117). Ob-R was found to be a 
product of the diabetes (db) gene and db/db mice were shown to be resistant to leptin (118). 
The Ob-R belongs to the class I cytokine receptor family and alternative splicing give rise to 
six receptor isoforms: Ob-Ra, Ob-Rb, Ob-Rc,Ob-Rd, Ob-Re and Ob-Rf. The long form, Ob-
Rb, is found in almost all tissues and appears to be the only form capable of transducing  
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FIGURE 1.2: LEPTIN RECEPTOR SIGNALING 
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the leptin signal while Ob-Re binds to circulating leptin and the short forms (a, c, d and f) are 
thought to aid in leptin transport across the blood-brain barrier (113,118-120). 
 Similar to other class I cytokine receptors, the main route by which leptin mediates its 
effects through receptors is the Janus kinase (JAK)-signal transducer and activator of 
transcription (STAT) pathway (119). Following leptin binding to the Ob-R, three main 
signaling cascades begin with the phosphorylation of tyrosine (Tyr) residues on the 
intracellular domain of Ob-R by noncovalently bound JAK2 (121). Tyr985 phosphorylation 
results in the activation of the Ras/Raf/ERK signaling cascade, whereas Tyr1077 and Tyr1138 
activate STAT proteins. JAK2 activity leads to the activation of the STAT signaling pathway, 
the (PI3K) pathway and the mitogen-activated protein kinase (MAPK) pathway.  
 Activated JAKs transphosphorylate each other, as well as other tyrosine residues 
(Tyr985, Tyr1138 and Tyr1077) of the Ob-R providing “docking sites” for downstream molecules 
such as STATs. At the end, Ob-R signaling by leptin results in STAT3 binding and the 
activation of STAT1, STAT5 and STAT6 which mediate the transcriptional effects of leptin 
upon entry into the nucleus. STAT3 has been shown to be particularly important for 
mediating the effect of leptin (74,122). Recruited STATs then become tyrosine-
phosphorylated by JAKs and dissociate from the receptor forming homo- or heterodimers. 
STAT dimers then translocate to the nucleus and act as transcription factors by binding 
specific response elements in the promoter regions of their target genes. (See Figure 1.2) 
(120,123,124). 
 The JAK/STAT pathway of cytokine signaling is under negative-feedback control of 
suppressors of cytokine signaling (SOCS) proteins. Members of the SOCS family are 
induced by a variety of cytokines and act as negative regulators of signaling by binding to 
phosphorylated Jak proteins or by indirect interaction with tyrosine phosphorylated receptors 
(106,125). Both SOCS1 and SOCS3 can inhibit Ob-R signaling; however, they each use 
different mechanisms. SOCS1 directly interacts with the kinase domain of JAK2 while  
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TABLE 1.3: CYTOKINE INDUCTION AND ACTION OF SOCS1 AND SOCS3 (ADAPTED FROM (126)) 
 
SOCS 
PROTEIN 
SIGNALING THAT INDUCES 
EXPRESSION 
SIGNALING THAT IS 
SENSITIVE TO INHIBITION 
REFERENCES 
SOCS1 IL-2, IL-4, IL-6, IL-10, INSULIN, 
IFN-α/β, IFN-γ, TNFα 
IL-2, IL-4, IL-6, IL-7, 
INSULIN, LEPTIN 
(127-134) 
SOCS3 IL-1, IL-2, IL-6, IL-10, INSULIN, 
LEPTIN, TNFα 
IL-2, IL-4, IL-6, INSULIN, 
LEPTIN, IFN-α/β, IFN-γ 
(127,132-136) 
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SOCS3 expression inhibits the tyrosine phsophorylation of Ob-R, thus providing an 
important feedback mechanism for receptor signaling (136,137). SOCS proteins are induced 
upon cytokine stimulation and attenuate signaling by various cytokine receptors allowing 
possible cross-regulation among several cytokine systems. For example, SOCS3 is induced 
by IL-2, IL-6 and leptin and can inhibit leptin, IL-2, IL-4, IL-6, IFN-α/β and IFN-γ signaling 
(126,127,132,133,135)(See Table 1.3). 
 
D.2.3. Leptin Resistance 
 
Following the discovery of leptin, it was initially hoped that exogenous administration 
of leptin might induce satiety and weight loss in humans (107,138). However, leptin therapy 
was found not to be an effective treatment for “normal” morbid obesity that is not due to rare 
congenital deficiency of leptin or leptin receptors (46,139,140). In the obese state, leptin 
concentrations are already high as a consequence of increased fat mass. The persistence 
of obesity and no significant response to this increased fat mass with a reduction in food 
intake in spite of increased leptin levels suggest that chronically elevated leptin levels can 
induce a state of leptin resistance (113). The identity of the crucial mediator(s) of leptin 
resistance still remains unclear; however, it is hypothesized that leptin resistance may occur 
due to a leptin-induced increase in SOCS3, which blocks the intracellular transmission of the 
leptin signal. Indeed, hypothalamic expression of SOCS3 is elevated in several rodent 
models of obesity (136,137,141). How does this occur? In vitro data shows that chronic, 
high-level Ob-R activation results in its own feedback inhibition, probably via SOCS3, 
effectively limiting leptin signaling during chronic exposure (Figure 1.3). It is also possible 
that other signals may increase SOCS3 or other mediators of leptin signaling in vivo 
including inflammatory mediators such as IL-6, TNFα, fatty acids and other lipids, and other 
activators of counter regulatory signals. These too have been found to be  
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FIGURE 1.3: SOCS SUPPRESSION OF LEPTIN SIGNALING AND LEPTIN RESISTANCE 
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elevated in rodent models and in human obesity. The data for central leptin resistance in the 
ARC is quite strong and suggests that the ARC is the most important site in the 
development of leptin resistance. The data for peripheral leptin resistance, such as in cells 
of the immune system is less clear (104,105,113,142-145).  
 
D.2.4. Leptin and the Immune System  
 
In addition to adipocytes, many other cell types are now known to secrete and/or 
respond to leptin (146). Leptin’s role in regulating immunity has been fueled by early 
observations of thymic atrophy in db/db mice (147). In addition, ob/ob mice are 
immunodeficient with increased susceptibility to bacterial and viral infections (148-150). The 
general consensus seems to be that leptin exerts a proinflammatory role, while at the same 
time protecting against infections (14). In experimental animal models, inflammatory stimuli 
acutely induce leptin mRNA and increase serum leptin levels (100). Leptin seems to exert its 
effects on immune cells through the JAK/STAT pathway. In peripheral blood mononuclear 
cells, leptin increases JAK2/3 and STAT3 phosphorylation, which promote proliferation and 
activation of T lymphocytes upon mitogen-stimulation (72) 
Leptin protects T lymphocytes from apoptosis and regulates T cell proliferation and 
activation. Leptin induces a shift toward a Th1 cytokine-production profile (151,152), which 
is necessary for recovery from a number of viral infections, including influenza. In mouse 
models, leptin is reported to stimulate the proliferation of T cell in vitro, to promote TH1 
responses and to protect T cells from apoptosis. Ob/ob mice display an increased thymocyte 
apoptosis and reduced thymic cellularity compared to wildtype controls and peripheral 
administration of leptin reverses these defects (101,153-155).   
In addition to its effects on T cells, leptin has been shown to affect the innate immune 
response. Leptin has been shown to influence monocyte activation, phagocytosis and 
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cytokine production. Macrophages from leptin-deficient mice have decreased phagocytic 
function and altered cytokine expression. Additionally, leptin can enhance oxidative species 
production in stimulated polymorphonuclear leukocytes and can inhibit the migration of 
neutrophils in response to classical chemoattractants (156-158). Overall, it appears that 
leptin increases the activity of phagocytes and may thereby contribute to host defense (153).  
Most of the data available on the effects of leptin on immunity stems from experiments 
utilizing mice. However, the effect of leptin on the human immune system is just now being 
explored. The presence of leptin receptors has been documented in human circulating CD4+ 
and CD8+ T lymphocytes. The few cases of leptin deficiency described in humans have 
demonstrated reduced numbers of circulating CD4+ T cells, impaired T cell proliferation and 
cytokine release, all of which are reversed by recombinant human leptin administration 
(159,160). It is unclear at this time whether leptin resistance, which is more common than 
leptin deficiency in adult obesity, is also associated with these same changes in T cells and 
cytokines, or whether leptin plays a role in immune alteration of obesity at all.   
Similar to leptin deficiency, severe malnutrition has been associated with thymic atrophy, 
reduced T-cell function and increased susceptibility to infection. These changes are in 
correlation with the sharp reduction in leptin levels observed at extremely low BMIs (161-
163). Taken together, experimental data indicate that chronic leptin deficiency differentially 
affects innate versus adaptive immune responses. Innate responses are altered by 
inadequate control of the inflammatory response while adaptive responses are severely 
attenuated. If peripheral leptin resistance causes a state similar to that of leptin deficiency in 
immune cells, this resistance could account for the immunodeficiences observed in obese 
individuals. 
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D.3 Obesity and Immunity  
Nutrition and immune function are intimately linked. Therefore, immunocompetence 
is dependent on nutritional status and can be easily dysregulated in states of imbalanced 
nutrition such as obesity (Figure 1.4). Lymphoid tissues have an extremely rapid turnover 
and appear to be particularly sensitive to nutrient imbalances, especially those which affect 
metabolic pathways and functions necessary for adequate immune defense (164). It is 
currently unknown exactly why obesity leads to changes in the immune system; however, 
many pathways such as nuclear factor kappa B (NF-κB) and Phosphoinositide-3 kinase 
(PI3K) are altered in the obese subject which have an important role in the immune 
response (164,165).  
 
D.3.1. Obesity and Immunity in Humans 
 
Epidemiological data support the idea that obesity can affect immune function in 
humans. In the hospital setting, obese patients are more likely to develop secondary 
infections and complications such as sepsis, pneumonia, bacteraemia and wound and 
catheter-related infections. Patients with increased BMI and adiposity also present a higher 
incidence of surgical site infections, which have been associated with increased risk of other 
wound complications, increased length of stay and increased risk of death (166-171). 
Obesity negatively affects pulmonary function, and hospitalized obese patients have been 
shown to be at increased risk for pulmonary aspiration and community-related respiratory 
tract infections (21,172). In the Health Professionals Follow-up Study and the Nurses Health 
Study II, increased BMI and weight gain (versus weight maintenance) were directly 
associated with increased risk for community-acquired pneumonia in women (173,174). 
Increased susceptibility to acute respiratory tract infection has also been shown to be 
associated with BMI in overweight children (175). In addition to increased susceptibility to  
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FIGURE 1.4: NUTRITION AND IMMUNE FUNCTION RELATIONSHIPS (ADAPTED FROM (164)) 
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respiratory tract infection, population-based studies have defined a significant association 
between obesity and asthma. In one of the more recent studies, Beuther and Sutherland 
(2007) report  that the odds of developing asthma nearly double in obese (BMI ≥30) 
compared with normal-weight individuals. In addition, it was estimated that approximately 
250,000 new cases/year of asthma be attributable to excess weight in the United States 
alone (176-178).  
More recent studies have found clinically important changes in the immune system of 
obese humans (179). Studies of cellular function in obese humans follow the trend of diet-
induced obese animal models and are mainly focused on ex vivo cellular functionality. 
Numerous studies exhibit a lowered capacity of lymphocytes from obese individuals to 
respond to mitogen stimulation (180). Neiman et. al. (1999) showed obesity was related to 
elevated leukocyte and lymphocyte subsets with lowered T and B-cell proliferation in 
response to mitogen stimulation (181,182).  These alterations in T cell subsets have been 
suggested to be linked to increases in TNFα and expression of other cytokines (183-186). 
Even less is known about the impact of obesity on the response to vaccination. A small set 
of studies has shown that obesity can impact seroconversion and that obese adults and 
children have reduced antibody titers in response to Hepatits B and tetanus vaccines (187-
189). 
Several studies have assessed immune functionality in obese individuals following 
weight loss or dietary restriction. The majority of these studies show increased immune 
responsiveness and improvement. For example, a study by Tanaka et al. (2001) showed 
increased T cell responsiveness to mitogen following a weight reduction program (190). It 
must be noted that these improvements have not been assessed in the long term after 
subjects have achieved and maintained “healthy” weight. Further research in this area would 
greatly increase the number of conclusions that could be drawn on the impact of obesity and 
the positive effect of weight loss on immunity.  
27 
 
D.3.2. Obesity and Immunity in Animal Models  
Numerous studies using genetically obese rodents (mainly as a result of leptin or 
leptin receptor deficiency) demonstrate a global impairment in immune function in these 
animals. Genetically obese animals exhibit marked thymic atrophy as well as diminished T 
and B cell populations (147,191). Genetically obese mice express decreased levels of IL-2 
versus lean animals, which may explain the lowered capacity of T cells to proliferate in these 
animals (192). In addition to reduced IL-2, decreased glucose uptake by lymphocytes in 
these animals may also inhibit proliferation (193). Apart from the reduced proliferation seen 
in genetically obese models, TNFα production has also been found to be increased in 
genetically obese animals which may influence lymphoid tissue development and induce 
apoptosis in lymphoid cells (180,194). Increased serum free fatty acids may also inhibit T 
lymphocyte signaling (192). As stated above, genetically obese animals provide an excellent 
model for observing the effects of extreme obesity; however, the complete lack of leptin 
signaling in these models lead to changes in immune system development and function 
which are considerably more pronounced than in diet-induced obese rodents and in obese 
human subjects. 
In diet-induced obese animals, similar, though less pronounced, impairment of the 
immune system has been found (180). The majority of these studies are similar to those in 
obese humans where immune cell function was assessed ex vivo. Studies in diet-induced 
obese animal models have shown obese mice had lower levels of mitogen-induced IL-2, 
although IFN-γ and IL-4 production was increased (195). Takahashi et al. (2003) found that 
diet-induced obese mice had increased levels of adipocyte derived mRNA for MCP-1 
(monocyte chemoattractant protein-1) as well as higher protein levels of MCP-1 in the 
plasma.  CD11b+ macrophage/monocyte population also was increased in the obese mice 
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(88). Additionally, studies with mice fed a high fat diet show impairment of DC function and 
altered T cell responsiveness (196).  
Genetically obese animals exhibit decreased resistance to bacterial and viral 
infections; however, there are few studies which observe the effects of infection in diet-
induced obese models (197,198). Previous studies in our lab have demonstrated that mice 
with diet-induced obesity have a dysregulated primary immune response to influenza 
infection. Following dietary treatment, influenza-infected DIO mice had 7 times greater 
mortality compared to lean controls. Degree of lung infiltration and pathology was seen to be 
increased at day 6 post infection. DIO mice had significantly decreased expression of 
IFNα/β and increased and delayed expression of pro-inflammatory cytokines and 
chemokines (199). In addition, dendritic cells from obese mice failed to efficiently present 
influenza antigen to T cells (200). 
 Although the evidence from both animal models of obesity and obese humans 
demonstrates immune impairment, surprisingly, very little is known about immune responses 
to viral infections in obese subjects. One virus, which constitutes a very real public health 
threat, is the influenza virus. An impaired response to influenza infection in obese 
individuals, especially in an increasingly obese population, would have grave 
consequences.  
 
E. Influenza and Public Health  
 
Influenza is a respiratory illness caused by the influenza virus. Spread through 
airborne transmission, these viruses are highly contagious and are responsible for a great 
deal of morbidity and mortality in the world (201). In any given year,  5-15% of the world 
population is infected with influenza virus resulting in 3-5 million cases of severe illness and 
500,000 deaths from influenza and influenza-related complications (202). Young children, 
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the elderly and people with chronic diseases are particularly susceptible to influenza-related 
complications including viral or bacterial pneumonia, dehydration, and death. (203). Very 
recently, the CDC has suggested that obese individuals are at a greater risk of morbidity 
and mortality from pandemic novel influenza H1N1 strain. Speculation on the cause ranges 
from excess adipose tissue constricting lung volume to chronic inflammation influencing the 
immune response (204-206). The estimated annual economic impact of influenza in the 
United States alone is $12-14 billion (207).  
In temperate climates, such as in the United States, flu outbreaks typically occur 
during the winter months from late November/December through March, but the onset, 
peak, duration and severity of the flu season can vary considerably from year-to-year. 
Typical outbreaks move though a community in 12 or more weeks; however, recent 
evidence has shown that there is no such thing as a typical year. For example, influenza 
A/Fujian/411/02 (H3N2) began to produce severe illness in children in October of 2003 
(208). Occasionally, and at relatively regular intervals, severe worldwide pandemic 
outbreaks occur which are less constrained by season. Historically, these pandemics occur 
at 10-40 year intervals and originate mainly in Asia (209). Three confirmed pandemics have 
occurred in the past century. First, the Spanish influenza pandemic in 1918-1919 claimed an 
estimated 50 million lives. In addition to the 1918 pandemic, the Asian (1957) and Hong 
Kong (1968-1969) pandemics resulted in 1-2 million deaths (210).   
During April 2009, a novel H1N1 virus was detected in two independently-collected, 
unrelated cases of influenza-like virus in California which was then traced back to a number 
of cases of severe respiratory illness in Mexico beginning in the town of La Gloria, Veracruz  
in mid-February 2009 (211,212). The virus was found to be genetically and antigenically 
unrelated to currently circulating human seasonal influenza strains and genetically related to 
viruses circulating in swine. This fact, in addition to the outbreak being localized in a 
Mexican pig farming region, raised immediate suspicion that the virus had gone through a 
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pandemic shift (212,213). Indeed, genetic analysis of the virus revealed that it is a triple 
reassortment of strains from human, avian and swine sources (214). By the end of April, 
international spread and clusters of human-to-human transmission in multiple countries 
prompted the WHO to declare an imminent pandemic (211). On June 11, 2009 the WHO 
issued a pandemic alert level of six which indicated the H1/N1/09 strain had reached all the 
criteria for a pandemic outbreak (215,216). The H1N1/09 pandemic strain has been found to 
have increased severity of illness versus the seasonal H3N2 virus (217,218); however, to 
date the virus seems to have not reached its pandemic projections. There is great concern 
that the H1N1/09 pandemic strain will go through antigenic drift over the coming influenza 
seasons and change its pathological potential, which could theoretically result in numbers of 
deaths similar to previous pandemic years. (219).  
 
F. Influenza Biology and Replication (Figure 1.5) 
 
 Influenza viruses are members of the Orthomyxoviridae family and are characterized 
by segmented, negative-strand RNA genomes. The most common of these viruses are the 
A, B and C genera with only influenza A and B able to infect humans.  Influenza A viruses 
are further classified by subtype based upon their surface glycoproteins: hemagglutinin (HA) 
and neuraminidase (NA).  Structurally, the influenza A virus is studded with these HA and 
NA glycoproteins (at a ratio of approximately four to one) projecting from a host cell-derived 
lipid membrane. A smaller number of matrix ion channel proteins (M2) span the lipid 
envelope. The viral envelope overlays an internal protein matrix (M1) which encloses the 
virion core. Inside the virion core reside the nuclear export protein (NEP) and the 
ribonucleoprotein (RNP) complex consisting of eight negative-sense, single-stranded viral 
RNA (vRNA) segments coated with nucleoprotein (NP) and the heterotrimeric RNA-
dependent RNA polymerase (220,221).  
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Figure 1.5: Lifecycle and replication of the influenza virus 
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Following infection, HA spikes on the surface of influenza viruses recognize and attach to 
sialic acid-containing receptors on host cells of the respiratory epithelium.   
Following attachment, the virus is endocytosed via clatherin-coated pits. Inside the 
endosome, the viral envelope fuses with the endosomal membrane releasing viral RNPs 
from the viral matrix into the cellular cytoplasm. Nuclear localization signals from viral 
proteins direct host cellular proteins to import the RNPs and other viral proteins into the host 
cell nucleus (222). Inside the nucleus, the viral RNA-dependent RNA polymerase uses the 
negative-sense vRNA to synthesize two positive-sense RNAs: messenger RNA templates 
for viral protein synthesis and complimentary RNA intermediates for subsequent 
transcription of additional negative-sense vRNA (223). Newly generated envelope proteins 
HA, NA and M2 as well as newly synthesized vRNA exported from the nucleus assemble 
into new virions at the apical plasma membrane  of the infected, polarized epithelial cells. 
Virions egress the cells through budding resulting in a new viral envelope derived from the 
host cell membrane (221,224,225). 
 
G. Immune Response to Influenza Infection (Table 1.4, Figure 1.6) 
 Infection with influenza virus leads to a coordinated immune response beginning with 
innate immune defenses responsible for limiting viral infectivity and replication. These innate 
defenses then signal to adaptive immune systems which are responsible for clearing the 
rest of the infecting virus and protecting the body again reinfection.  
 
G.1. Innate Immune Response 
 
The innate (non-specific) immune response is the first line of defense. Found in most 
living organisms, this system detects invading pathogens and promotes a coordinated 
pattern of cytokine secretion which acts to inhibit viral replication and induce  
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TABLE 1.4 CYTOKINES AND CHEMOKINES EXPRESSED DURING INFLUENZA VIRUS INFECTION [ADAPTED FROM 
(226)] 
 
CHEMOKINE/CYTOKINE FUNCTION PRODUCED BY 
IFNα/β INHIBIT VIRAL REPLICATION 
PROMOTE NK CELL PROLIFERATION AND 
CYTOXICITY 
ACTIVATE ANTIGEN-SPECIFIC T CELLS 
DENDRITIC CELLS 
RESPIRATORY EPITHELIUM 
   
IFNγ INHIBITS VIRAL REPLICATION 
STIMULATES CTL MEDIATED KILLING 
INCREASES MHC I EXPRESSION 
ACTIVATES MACROPHAGE AND NEUTROPHILS 
PROMOTES T-CELL PROLIFERATION 
T CELLS 
NK CELLS 
   
TNFα DIRECT ANTIVIAL EFFECTS 
NEUTROPHIL CHEMOATTRACTANT 
STIMULATES MACROPHAGE PHAGOCYTOSIS    AND 
PRODUCTION OF IL-1 
INCREASES VASCULAR PERMEABILITY 
T CELLS 
MONOCYTES/MACROPHAGE 
DENDRITIC CELLS 
NEUTROPHILS 
   
IL-1 INCREASES EXPRESSION OF ADHESION FACTORS 
ON ENDOTHELIUM 
INCREASES VASCULAR PERMEABILITY 
STIMULATES IL-6 PRODUCTION 
MONOCYTES/MACROPHAGE 
DENDRITIC CELLS 
   
IL-2 GROWTH, DIFFERENTIATION AND SURVIVAL OF 
ANTIGEN-SELECTED T CELLS 
T CELLS 
   
IL-6 PRO-INFLAMMATORY CYTOKINE 
ACTIVATES T CELLS 
RESPIRATORY EPITHELIUM 
T CELLS 
MONOCYTES/MACROPHAGE 
DENDRITIC CELLS 
   
IL-12 PROMOTES DIFFERENTIATION OF NAÏVE T CELLS TO 
TH1 
ENHANCES CYTOTOXIC ACTIVITY OF NK CELLS AND 
T CELLS 
STIMULATES IFNΓ PRODUCTION BY DENDRITIC 
CELLS AND NK CELLS 
MACROPHAGE 
DENDRITIC CELLS 
   
MCP-1 RECRUITS MONOCYTES/MACROPHAGE, DENDRITIC 
CELLS AND T CELLS 
RESPIRATORY EPITHELIUM? 
MACROPHAGE 
?? 
   
MIP-1α/β RECRUITS MONOCYTES/MACROPHAGE, T CELLS 
ACTIVATES NEUTROPHILS 
MONOCYTES/MACROPHAGE 
DENDRITIC CELLS 
T CELLS 
NEUTROPHILS 
   
RANTES RECRUITS T CELLS, EOSINOPHILS AND BASOPHILS, 
MONOCYTES/MACROPHAGES, DENDRITIC CELLS 
ACTIVATES T CELLS 
RESPIRATORY EPITHELIUM 
T CELLS 
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proinflammatory factors which aid in reducing viral spread. Influenza viruses preferentially 
infect the epithelial cells and macrophages of the respiratory tract (221). Influenza-infected   
epithelial cells and macrophages respond to infection by producing antiviral, chemotactic, 
proinflammatory and other immunoreguatory cytokines (221,227,228). Type I Interferons 
(IFNα and IFNβ), interleukins 1 (IL-1) and 6 (IL-6) and tumor necrosis factor alpha (TNFα) 
are all part of these signals. IFNα and IFNβ  are major antiviral cytokines and can mediate 
direct antiviral activity of cells. In addition, these cytokines also have antiproliferative and 
immunomodulatory function. Proinflammatory cytokines IL-1β, IL-6 and TNFα are readily 
produced by infected macrophages but do not contribute directly to antiviral immunity (229). 
IL-1β and TNFα enhance the inflammatory response and further activation of antigen 
presentation. IFNα/β increases the recruitment of monocytes/macrophages and T cells to 
the site of infection, enhances antigen presentation on macrophages and dendritic cells and 
acts to promote the TH1 response (221,229-232). 
Innate immune mechanisms exist to restrict the replication of influenza viruses within 
the host early during infection allowing for the development of pathogen-specific adaptive 
responses which are needed for viral clearance. Many of the key players in innate immunity 
act to signal and promote the adaptive response.  Dendritic cells (DC) are principal antigen 
presenting cells and are the initiators and modulators of the adaptive immune response 
(233). DCs can be directly infected with influenza; however, they uptake virus for 
presentation to T cells on the major histocompatibility complexes. Cytokines produced by 
DCs during antigen presentation play an important role in the activation and polarization of T 
cell responses. During influenza infection, DCs produce IL-12 which stimulates Th1 
responses and functions directly on CD8+ T cells to augment viral clearance and IFNγ 
production (233,234). DCs also produce IFN-α/β. The production of IFN-α/β by DCs, plus 
their production of IL-12 greatly impacts natural killer (NK) cell expansion and activation 
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(235). NK cells are cytotoxic lymphocytes that kill virally infected cells. The ability of NK cells 
to recognize virally infected cells relies on a system of recognition by their receptors on NK 
cell surfaces. Killer-inhibitory receptors recognize MHC class I molecules expressed by all 
nucleated cells. Infection with influenza results in the down regulation of MHC Class I 
molecules leading to activation of NK cell killing (236). Therefore, dysregulation of the innate 
response can lead to greater viral spread and decreased promotion of viral clearance by the 
cells of the adaptive immune response (237).  
 
G.2. Adaptive Immune Response 
 
Composed of highly specialized, systemic cells, the adaptive immune system acts to 
eliminate pathogens from the body. Development of an effective adaptive response is highly 
dependent on signals received during the innate response (See Figure 1.6). Secretion of 
cytokines by innate cells early during infection promotes the development of CD8+ cytotoxic 
T cells and CD4+ helper T cells. During the initial stages of infection, APC such as DC  help 
to “select” cells that exhibit the appropriate pathogen-specific receptors. Upon viral 
exposure, dendritic cells of the innate immune response in the lungs mature, take up 
antigen or are directly infected by the virus, and selectively migrate to draining lymph node 
(LN; cervical and mediastinal) where they display antigen peptides to naïve T cells. 
Interaction between APCs and its matching T cell receptor (TCR) promotes the proliferation 
and development of a population of antigen-specific T cells that enable the adaptive 
response (238). Additionally, optimal T-cell activation requires co-stimulation of the T cell 
receptor CD28 contact with CD80/CD86 on the APC (239).  
Naive CD4+ T cells can differentiate into helper T cells (Th) with either a Th1 or Th2 
phenotype, regulatory T (Treg) cells or Th17 cells. CD4
+ T cell differentiation depends on the  
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FIGURE 1.6: IMMUNE RESPONSE TO INFLUENZA INFECTION 
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type of pathogen and by the cytokines that are secreted during presentation on MHC Class 
II. During influenza infection, IL-12 secretion from DC polarize the CD4+ T cell toward a Th1 
phenotype, resulting in IL-2 and IFN-γ production which then activate CD8+ T cells.  
Although CD4+ T cells help promote CD8+ activation during influenza infection, it is not 
required as mice that lack MHC Class II molecules, elicit a normal CD8+ effector T cell 
response (240).   
Resolution of a viral infection often relies on the induction of a CD8+ T cell response 
(241). CD8+ T cells actively identify and eliminate virally infected cells. During an influenza 
virus infection, T cell responses peak between day 7-10 post infection (p.i.) resulting in viral 
clearance by day 15 (242-245). Upon contact with an infected cell, CD8+ T cells act to inhibit 
viral replication and to destroy virally infected cells. These functions are achieved through 
the secretion of IFNγ and perforin/granzyme B as well as Fas/FasL pathway (246). CD8+ 
CTLs recognize MHC class I antigenic-peptide complexes on virus-infected epithelial cells 
and kill cells using perforin and granzymes (247-249). In the perforin/granzyme B pathway, 
CD8+ T cells insert perforins into the membranes of infected cells which is followed by the 
release of granzymes. This activates caspases and results in apoptosis. Alternatively, 
caspase activity can be activated by Fas/FasL interaction. IFN-γ, which is produced by 
cytokine stimulation or by cell-cell interactions, is not directly involved in the lysis of infected 
cells; however, IFN-γ secretion enhances the development of cell-mediated immunity, 
activates macrophages, and increases antigen presentation (250-252). 
 Apart from the T cell response, the B-cell mediated response to influenza infection 
has long been thought to play a less important role; however, studies have shown that B-cell 
deficient mice have significantly reduced survival when challenged with A/PR/8 but not when 
challenged with influenza X-31. These studies indicate that B cells make a significant 
contribution to recovery during a substantial challenge with influenza (253). Following viral 
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infection, influenza-specific naïve B cells recognize viral particles or are presented antigen 
by helper T cells. The activated B cells then proliferate and differentiate into resting memory 
cells and antibody-secreting plasma cells (237). Antibodies directed towards the viral 
proteins then function to help eliminate viral replication and spread. Ergo, a coordinated 
cross-talk between the innate and adaptive immune responses is important for a robust 
response and protection against infection with influenza virus. 
 
H.  Protection against Influenza Infection 
 
H.1. Vaccination 
 
Traditionally, protection against influenza has been achieved using inactivated 
influenza virus vaccines, which were first employed over 60 years ago and are still the 
principal mode of immunization, although live attenuated vaccines are beginning to be used 
worldwide (254,255). Each year, an advisory committee of the Food and Drug 
Administration and WHO uses laboratory studies of flu strains and epidemiological data of 
flu activity to determine three viruses (two different subtypes of influenza A viruses and one 
influenza B virus) to target in generating the flu vaccine for the following fall and winter.  
Usually one or two virus strains that the vaccine targets are changed each year. In the US, 
the Advisory Committee on Immunization Practices for the prevention and control of 
influenza have identified groups that should be targeted for annual vaccination including 
persons at risk for complications of influenza as well as those likely to transmit influenza to 
other high-risk persons. All persons wishing to avoid influenza are encouraged to receive 
the vaccine (256) 
Studies of influenza vaccine efficacy and effectiveness have used a variety of 
outcomes or case definitions that can dramatically affect the numbers reported (257). In the 
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best case scenario, criteria for the effectiveness of the vaccine is based on the induction of 
an adequate level of virus-neutralizing (hemagglutination-inhibiting) antibodies in the serum. 
Antibodies against influenza virus are primarily directed against the envelope glycoproteins 
of the virus, the hemagglutinin and the neuraminidase. It has been well-established that the 
major target for neutralization of the virus is the hemagglutinin, and circulating levels of 
antibody against the hemagglutinin can prevent infection with influenza (258). However, the 
overall efficacy rate of vaccination, particularly in the high-risk elderly populations, is 
approximately 60%. One of the reasons suggested for the suboptimal efficacy is age-related 
changes in the cell-mediated component of the immune response. Antibody production by B 
cells requires a CD4+ T cell response, and thus a suboptimal CD4+ T cell population will lead 
to lowered antibody production (237). 
The effectiveness of the flu vaccine in protecting individuals against illness or serious 
complications of flu depends primarily on the immunocompetence of the person receiving 
the vaccine, previous exposure to influenza and flu vaccine, and the similarity between the 
virus strains in the vaccine and those infecting the population (259).  When the match 
between vaccine and circulating strains is close in a given flu season, flu vaccine prevents 
illness in approximately 70%-90% of healthy persons younger than age 65 years.  Among 
community-dwelling elderly persons, flu vaccine is 30%-70% effective in preventing 
hospitalization for pneumonia and influenza.  Among elderly nursing home residents, flu 
vaccine can be 50%-60% effective in preventing hospitalization or pneumonia and 80% 
effective in preventing death from influenza (260-262) 
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H.2. Antigenic Drift and Shift 
 
Hosts which survive a primary infection with influenza virus are generally immune to 
reinfection with the same virus. Despite this protection, influenza infections continue to infect 
individuals yearly. This lack of immune protection from repeated infection stems from the 
fact that influenza structural proteins have robust structural plasticity and can tolerate a 
number of amino acid substitutions. The genomes of influenza viruses consist of eight 
separate segments of single-stranded, negative-sense RNA. During viral replication inside 
of the cell, the RNA-dependent RNA polymerase is highly error-prone resulting in a large 
variation in viral RNA. Since antibodies to HA neutralize viral infectivity, influenza virus 
strains evolve frequent, single amino acid changes in the HA molecule. These relatively 
minor changes, termed antigenic drift, accumulate and eventually result in a strain that is no 
longer effectively neutralized by host antibodies and can produce a productive infection 
(263).  
In addition to the small mutations resulting from drift, the segmented genome of the 
influenza virus enables occasional gene reassortment during a dual infection with two 
different influenza viruses. In this situation, the resultant influenza virus strain acquires the 
HA segment, and possibly the NA segment, from a completely different influenza virus 
subtype. This antigenic shift can happen in cells infected with different human and animal 
influenza viruses and may result in a completely novel set of surface glycoproteins which the 
human populations has not previously encountered. A pandemic occurs when the human 
population is susceptible, but immunologically naïve, to this new virus. Indeed, it has been 
confirmed that both the Asian (H2N2) and Hong Kong (H3N2) pandemics were reassortants 
containing genes derived from previously circulating human influenza subtypes and genes 
that appeared to be derived from avian subtypes (263,264). Interestingly, gene sequences 
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of the 1918 pandemic strain from formalin-fixed lung autopsy samples and from unfixed 
tissue from an Alaskan pandemic victim indicate that the 1918 virus may have arisen solely 
from adaptive mutations and not by reassortment (265,266). 
 
H.3. Humoral versus Cell-mediated Immune Memory 
 
A vaccine which promotes a robust memory B cell antibody-based response to the 
surface proteins of one strain of influenza is likely to be ineffective for a strain encountered 
the next season expressing different surface proteins (267). However, there are several 
internal viral proteins that are highly conserved among influenza viruses, and therefore do 
not experience the drift and shift problems seen with the external proteins.  Although these 
proteins do not generate an effective antibody response because they are not exposed on 
the surface of the virus and, therefore, not accessible to B cells, influenza-specific T cells 
can recognize these proteins. Memory T cells generated during a primary influenza infection 
can target these internal proteins common to influenza strains, making them effective 
against encounters with heterologous virus stains. The ability to generate functional memory 
T cells, either during primary infection or by vaccination, has proven to be protective against 
potentially lethal influenza strains exhibiting completely different surface antigens (268). 
Indeed, exploiting this know capability of memory CD8+ T cells to recognize a broad range of 
heterosubtypic viruses is currently a hot focus of vaccine development (269,270) 
 
H.3.1. Memory CD8+ T cell Generation 
 
CD8+ T cell responses have evolved to specifically eliminate pathogens and to 
protect against reinfection (271,272). The generation of long term immunity is dependent on 
the formation a pool of long-lived memory T cells.  During infection with influenza A/PR/8 in 
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a rodent model, lack of CD8+ cells results in decreased viral clearance and eventual 
morbidity (273). Initial recognition by a naïve CD8+ T cell of a foreign peptide/major 
histocompatibility complex (MHC) class I on an antigen presenting cell (APC) results in rapid 
clonal expansion and gain of effector function. The extent of the influenza-specific CD8+ 
effector T cell response can be related to viral load which is, presumably, reflective of 
antigen load on DCs (274). As in the primary response, upon contact with an infected cell, 
influenza-specific memory CD8+ T cells act to inhibit viral replication and to destroy virally 
infected cells. These functions are achieved through the secretion of IFNγ and 
perforin/granzyme B as well as Fas/FasL pathway (246). Following infection, activation and 
expansion of naive influenza-specific CD8+ T cells occur in the draining LN (242,244) These 
cells then migrate and localize to the lungs and infected airway epithelium where they exert 
their effector functions, producing antiviral cytokines and lysing target cells presenting viral 
determinants for which they bear a specific T-cell receptor (242,244,247)  
Following viral clearance, the activated effector T cells are no longer needed and 
activated short-lived effector cells (SLEC) responding to the primary infection are eliminated 
from the antigen-specific population (237,275). Contraction of activated CD8+ T cells results 
in a pool of memory cells representing ~5 to 10% of effector CD8+ T cells found at the peak 
of expansion during primary infection (276-278). Cessation of the antigenic stimulus prompts 
the activated effector cells to undergo activation-induced cell death (AICD). This apoptosis 
can be induced by a number of mechanisms including interaction of the Fas molecule on the 
T cell surface with the Fas ligand, a member of the TNF family of cytokines (237). 
Downregulation of the protective Bcl-2 gene during activation of effector CD8+ T cells leaves 
the cells vulnerable to Fas/caspase contraction, mainly mediated through the proapoptotic 
molecule Bim. Activation of Bim leads to proapoptotic factors being released from the inner 
mitochondrial membrane into the cytosol, such as cytochrome c which contributes to the 
formation of the apoptosome and the subsequent activation of the caspase cascade (237). T  
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FIGURE 1.7: GENERATION OF MEMORY T CELLS DURING PRIMARY INFECTION 
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cells lacking Bim undergo normal expansion but are more resistant to contraction (279). 
Effector CD8+ T cells with increased Bim and reduced Bcl-2 expression, generated through 
a knockout of the Id2 transcription factor, have increased contraction following the effector 
phase (280). The extent of contraction can be modulated by the extent of infection duration 
and resulting inflammatory signals. Short-term pathogen infection decreases the size of the 
resultant memory pool while insufficient duration or quality of TCR signal or other signals 
can lead to increased contraction and a reduction of the memory cell pool (276,278,281). 
 
H.3.1.1. Delineation of Memory versus Primary Effector T cells (Figure 1.8) 
Recent studies of the generation of long-term immunity and efficacious vaccination 
against viral agents have begun to focus on the generation of large numbers of long-lived, 
antigen-specific CD8+ memory T cells. From these studies, it has become apparent that 
generation of function CD8+ memory T cells requires a “balancing act” between memory cell 
potential and terminal differentiation into full effector T cells (282). Antigen density on the 
dendritic cell and time of contact with the APC, costimulatory factors and signals and levels 
of inflammatory cytokines could play a role in programming the development of memory 
potential (283). The lack of an early definitive marker that can distinguish an effector cell 
from a memory cell hampers a clear definition of when bona fide memory cells are 
generated during a CD8+ T-cell response; however, studies have shown altered T cell 
responses can lead to changes in memory cell populations and function. Timing, location 
and amount of exposure to antigen during CD8+ T cell development appear to be very 
important.  
Memory CD8+ T cells are preferentially established in draining lymph nodes at early 
(days 1-3) and late (day 28) but not acute (days 7-10) time-points after influenza infection. 
The least efficient population for transfer of memory is the highly activated day 8-10 
population (284). While it is clear that early and late events also shape CD8+ T-cell memory,  
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FIGURE 1.8:  MODELS OF MEMORY T CELL DIFFERENTIATION 
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TABLE 1.4: PHENOTYPIC CHARACTERISTICS OF SLEC AND MPEC (ADAPTED FROM (285-287)) 
 
 SLEC MPEC 
T-BET HI LO 
EOMES LO HI 
BLIMP-1 HI LO (TCM) /INT (TEM) 
BCL-2 LO HI 
IL-7R LO HI 
KLRG1 HI LO 
CD62L LO HI (TCM) /LO (TEM) 
CCR7 LO HI (TCM) /LO (TEM) 
GRANZYME B + - 
IFN-γ 
+ - 
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studies show that a brief contact with antigen might be all it takes to set up a developmental 
program that will ultimately generate T cells with memory characteristics. Initial dose, but not 
the duration of acute infection, determines the magnitude of CD8+ T-cell expansion. Also, 
expansion is highly dependent on the numbers of naïve T cell precursors recruited to the 
response (276). Programming of the CTL and memory responses have been shown to be 
accomplished during the first 2-3 days of infection, indicating the quality and context of the 
antigenic signal received is very important for determining CD8+ T cell fate (288).   
Compared with primary effector T cells, memory CD8+ T cells exhibit less terminally 
differentiated phenotypes because they are multipotent, go through self-renewal and have a 
high proliferative potential and increased longevity (289). The ability to differentiate between 
effector CD8+ T cells that are destined to survive and become long lived memory CD8+ T 
cells (memory precursor effector cells; MPEC) from those which will undergo activation-
induced cell death (AICD) post clearance (short-lived effector cells; SLEC) has greatly 
improved using a combination of functional criteria and surface marker expression. For 
instance, IL-7R and KLRG1 are inversely expressed on MPEC and SLEC with MPEC being 
KLRG1lowIL-7Rhigh while SLEC are KLRG1highIL-7Rlow (290).  However, it has been difficult to 
track the developmental lineage between MPEC and SLEC because the memory T cell 
population appears to continuously evolve over time post infection (290-293). Also, it must 
be noted that MPECs do not “bypass” the effector cell stage and therefore “memory” and 
“effector” fates does not mean that the “memory” fated T cells do not acquire effector 
functions during the primary infection. Several developmental models exist to explain how 
CD8+ T cells gain or maintain memory cell potential while others do not.   
The two most currently debated models are the “linear differentiation model” and the 
“bifurcative differentiation model” (Figure 1.8). In the linear differentiation model (Figure 
1.8A), stimulation of naïve T cells with antigen in the presence of environmental factors such 
as costimulation and inflammation leads to a population of effector T cells. Effector T cells 
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can then become either MPEC or SLEC depending on the extent of environmental cues 
(239,282,294). These environmental cues can be considered to have a “Goldilocks effect” 
(Figure 1.8A) where increased levels of inflammation, antigen presentation, costimulation, 
etc. can drive the differentiation towards an increased effector population and thereby 
decreasing memory potential (275,294-296) 
In the bifurcative differentiation model (Figure 1.8B), differentiation between SLEC 
and MPEC occurs based on initial antigen recognition and that one T cell can give rise to 
two daughter cells with different differentiation fates. Following T cell contact with an APC, 
the distal daughter (the daughter arising from the side of antigen contact) gives rise to 
MPEC and the proximal daughter (the daughter cell arising from the side opposite of antigen 
contact) gives rise to SLEC (294) The current hypothesis suggests that both the linear and 
bifurcative differentiation models can be combined (Figure 1.8C) resulting in a model where 
memory T cell versus effector T cell fate then becomes a very fine tightrope between SLEC 
and MPEC generation. Initial antigen contact stimulates inherent programming of  effector T 
cells. The remainder of the expansion phase is then controlled by the duration and intensity 
of other signals including inflammation and costimulation which may control the expression 
of key transcription factors such as T-bet and Blimp-1 (275,282,297). 
 
H.3.1.2. Effect of Antigen Presentation and Costimulation on Memory T cell 
Generation 
 
     Infection results in the upregulation of innate anti-viral responses which act to defend 
against a pathogen. Subsequently, cross talk between cells of both arms of the immune 
system promotes the activation of an adaptive response. APCs, such as dendritic cells 
(DCs) and macrophages (MΦ), act as mediators in this cross talk. Initiation of the CTL 
response has been shown to be dependent on MHC Class I presentation of peptide 
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displayed by bone-marrow derived APCs such as DCs and macrophages (298). Both DCs 
and MΦ are capable of stimulating naïve T cells in vitro; however, in vivo studies have 
strongly suggested that DCs are essential for the priming of naïve precursors while MΦ may 
not play as prominent of a role (299,300). The presence of DCs, their interaction with T cells 
and even their level of activation have all been found to affect T cell priming and the 
subsequent primary and secondary T cell responses (301,302). Vaccination with peptide 
coated dendritic cells results in accelerated generation of the CD8+ memory response (303).  
 Costimulation has also been found to be important for the generation and 
functionality of memory T cells. While costimulation has beneficial effects on proliferation 
and cytokine production in naïve T cells, increased costimulation (or lack of costimulation) 
can have a negative effect on the generation and subsequent functionality of 
effector/memory CD8+ T cells (304). The activation of naïve T cells requires receiving two 
signals from professional APC. The first signal is provided by the TCR following recognition 
of a viral antigen presented by the MHC. The second signal is provided by CD28 on the 
naïve T cell binding to its ligands, CD80 and CD86, on the APC. CD28 promotes the 
assembly of the T cell signaling complex and amplifies the signal generated by the TCR 
(305). Additionally, CD28 also increases cell cycle activity via enhanced production of IL-2 
and promotes survival by upregulating antiapoptotic molecules (306-308). Lack of CD28 
costimulation leads to a greatly reduced primary response and subsequent deficiency in 
memory cell generation (309-311). In addition to CD28, several TNF receptor family 
molecules including CD27 and CD40 have also been considered to be important 
costimulatory receptors (312,313). CD27 is expressed on lymphoid cells and its expression 
is upregulated upon priming. The ligand of CD27, CD70, is exclusively expressed on 
activated T cells and mature DCs (314,315). Thus, CD27-CD70 interaction is important for 
both T cell-DC interaction in the lymphoid organs as well as T cell-T cell communication in 
peripheral sites of infection. Lack of CD27 in mice during an influenza infection results in 
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decreased generation of antigen-specific CD8+ T cells in the lungs and, therefore, 
decreased memory populations over time (316,317). CD40 is expressed constitutively on all 
APCs while its ligand (CD40L; CD154) is expressed mainly on activated CD4+ T cells(318). 
Binding of CD40 to CD40L results in APC activation and can be considered a form of CD4+ 
“help” to promote and induce antiviral CD8+ T cell responses as well as production of 
memory cell populations (319-321). Expression of both CD40 and CD40L have been shown 
to affect memory cell generation, most notably with decreased numbers of memory cells 
generated in CD40L-/- mice and absence of CD40 signaling results in impaired CD8+ T cell 
memory irrelevant of the presence of CD4+ T cell help (322,323). 
 
H.3.1.3. Effect of Inflammation on Memory T cell Generation 
 
     Recent evidence also points out that inflammatory signals received during the primary 
infection can also determine the size and function of the memory cell pool. Inflammation can 
act as a “third signal” in the determination of the balance of effector and memory 
differentiation. Increased inflammation is associated with increased primary effectors but 
decreased memory precursors and differentiation into long-term memory. Reduced 
inflammation leads to reduced T cell contraction and greater numbers of CD8+ memory T 
cells (281). Increased expression of the proinflammatory cytokine IL-12 results in decreased 
memory generation. Mice lacking IL-12 (p35-/-) have greater numbers of memory cells, 
reduced contraction and increased protection from secondary infection, despite a weaker 
primary CD8+ response (295,324).  Induction of inflammation without altering the duration of 
DC antigen display prevented the rapid generation of CD8+ memory cells in wildtype mice, 
but not in mice lacking IFN-γ receptor (303). Additionally, IFN-γ knockout mice have 
increased levels of influenza-specific CD8+ T cells in the spleen and reduced levels in 
bronchioalveolar lavage fluid following infection (325). The adverse effect of inflammation on 
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T cell development may help to ensure proper viral clearance and only allow antigen-
specific memory cell generation after resolution of infection (326).   
 Several transcription factors have been shown to coordinate and regulate the 
balance between MPEC and SLEC (275,282,290,297,327) (Table 1.4). The transcription 
factor T-bet (Tbx21) is the master regulator of type I effector differentiation whose 
expression is considerably enhanced and sustained in the presence of  IL-12 (282,290,328). 
Recent evidence suggests that inflammation-induced T-bet can control effector and memory 
fate decisions in CD8+ T cells because increased differential expression of T-bet leads to 
differentiation towards SLEC and away from MPEC. In an experimental model of 
inflammation, T-bet was expressed in CD8+ T cells according to the amount of inflammation 
creating a gradient of T-bet in which high T-bet expression induced SLECs and low 
expression promoted MPECs (282,290,295,324). Another transcription factor, 
eomesodermin (Eomes) is proposed to promote memory formation (327). Moreover, IL-12 
induces T-bet but inhibits eomesodermin expression to favor effector versus memory 
generation (329). Interestingly, another transcription factor, Blimp-1, is also thought to be 
involved in MPEC versus SLEC differentiation. Increased expression of Blimp-1 is found to 
enhance the formation of SLEC and Blimp-1 deficiency promotes the formation of MPEC 
(330-332).  
 
H.3.1.4. The Effect of Cellular Metabolism and Nutrient Sensing on Memory T cell 
Generation 
 
 Adding to the complexity of MPEC versus SLEC differentiation, CD8+ T cell 
metabolic switching has now also been associated with effector versus memory generation 
(333). The energy-sensitive kinase mammalian target of rapamycin (mTOR) has the ability 
to sense cellular metabolic state, extracellular nutrient availability, presence of growth 
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factors/cytokines, and control key cellular processes that govern cell fate such as 
apoptosis/autophagy, proliferation, and cell growth (334-338). Very recently, mTOR activity 
has also been associated with generation of memory CD8+ T cells. Araki et al. (2009) have 
shown that modulation of mTOR function by rapamycin treatment affected memory 
generation during both the expansion and contraction phases of the T-cell response. During 
the expansion phase it increased the number of memory precursors and during the 
contraction phase it accelerated differentiation into memory T cells (339). Taking this idea 
one step further, Rao et al. (2010) have shown that mTOR can act as a “rheostat” in 
programming of naive CD8+ T cells for MPEC and/or SLEC fate by regulating expression of 
T-bet and Eomes. Inhibition of mTOR activity by rapamycin blocked T-bet expression and 
promoted memory-precursor generation (340) 
 
H.3.2. Phenotypic Characteristics of Memory CD8+ T cells 
 
Following influenza infection, long-lived influenza-specific CD8+ memory cells can be 
found in the lung airways, spleen, lymphatic system, liver and circulation (341). In addition to 
anatomical location, subsets of memory CD8+ T cells can be distinguished by phenotype 
(surface marker expression) and function. In the classical differentiation, central memory T 
cells (TCM) are found in secondary lymphoid organs and express CD62L and CCR7. Effector 
memory T cells (TEM) lack the expression of CD62L and CCR7 and have a wider distribution 
in the peripheral organs and tissues (341-343). Memory CD8+ T cells can also be classified 
based upon “activation phenotype”, independent of effector-/central-memory phenotype. 
Antigen specific CD8+ T cells are separated based on expression of markers which 
distinguish quiescent and semi-activated memory T cell subsets and can be used to define 
three distinct subpopulations (CD27hi/CD43hi, CD27hi/CD43lo, CD27
lo/CD43lo) (292). Also 
outside of effector and memory phenotype, extent of expression of CD127, 4-1BB and OX40 
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directly correlate to the extent of memory cell generation and their capacity for secondary 
expansion (316,317). 
 
H.3.3. Memory CD8+ T cells and Protection Against Influenza Infection 
 
It is quite clear that influenza-specific memory CD8+ T cells are protective against 
infection with heterologous strains. The protective effect of memory T cell populations 
against influenza infection has been shown in a number of models including against the 
highly pathogenic H5N1 viruses (344). Prime-challenge with an H9N2 isolate was protective 
against A/Hong Kong/156/97 (H5N1) (345) and a double-priming with both X-31 and PR8 
was protective against one of the most lethal H5N1 strains (268).  However, there are a 
number of factors that are vital for an effective memory T cell response including anatomical 
location of infection and memory cell populations, quantity and quality of memory T cells 
present as well as timing of the memory CD8+ T cell response. 
 
H.3.3.1. Memory T cells in the Respiratory Tract 
 
For a memory T cell to be effective in participation against reinfection, it must be 
present at the site of secondary infection. Memory CD8+ T cells persist in both the airways 
and parenchyma of the lungs following the resolution of a respiratory virus infection (346-
348).  Airway memory cells are localized primarily in the upper respiratory tract and can be 
easily obtained by bronchoaveolar lavage (349).  These memory cells are exclusively of TEM 
phenotype and have also been shown to express activation markers IL-7Rα, CXCR3, CD44, 
CD43, CD25 and CD69 (350-352). Specific to lung airway environment, CD8+ memory cells 
in the airway downregulate the T cell migration factor LFA-1 (CD11a) which is thought to 
trap them in the lung and prevent them from reentering circulation (353-355). In contrast to 
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the cells of the lung airways, memory cells found in the lung parenchyma (BALT/NALT 
associated) are composed of a mixture of TCM and TEM phenotypes and have a high 
expression of LFA-1 (356,357). Memory cells found in the secondary lymphoid organs (LN, 
spleen) are also of mixed TEM/TCM phenotype; however, phenotypic composition gradually 
stabilizes on a more TCM  population over time post infection (358,359). 
Influenza-specific memory CD8+ T cells will preferentially migrate to the lung tissue. 
Indeed, memory CD8+ T cells will preferentially migrate towards the site of greatest antigen 
specificity. Tissue-specific homing of memory cells allows for increased efficiency of 
adaptive response by providing increased numbers of antigen-specific T cells at the 
anatomical site most likely for reinfection (360). Migration of TCM from lymphoid to 
nonlymphoid tissue results in the conversion to a TEM phenotype (361). Additionally, the lung 
airway environment itself has been shown to directly influence surface markers and 
maintenance on CD8+ memory cells in the absence of antigenic exposure. Memory cells 
isolated from the spleen and transferred intratracheally into the lungs downregulate LFA-1, 
CD27, CD127 and Ly6C and increase CD69 while the same cells given intraperitoneally do 
not go through this change (353,362). Gene expression profiles of CD8+ memory cells in 
lung airway and spleen generated during influenza infection reveal a “focusing” of genes to 
favor effector function in the airway environment (363).   
 
H.3.3.2. Memory T cell Function during Secondary Influenza Challenge  
  
The fundamental characteristic in describing a T-cell response is its magnitude. This 
magnitude is generally defined as both number of responding cells and their ability to clear 
the viral infection. Antigen-specific memory CD8+ T cells inherently have greatly increased 
activity and effector function (Thomas et al, 2006). Following a secondary challenge with 
influenza virus, non-proliferating memory CD8+TEM in the lung airways are able to respond to 
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initial viral loads by generating inflammatory signals (such as IFN-γ) to induce the antiviral 
response (364,365). 
Quantity of available memory T cells is also important. The protective value of CD8+ 
TEM memory cells is strongly correlated to the ability to exert effector function at the site of 
infection (366). Reduction in the relative number of memory T cells in the lung airways has 
been correlated to a decline in the overall recall response to viral challenge regardless of 
stable numbers of splenic TCM (346,367). In addition, during a secondary response, 
recruitment of TEM to the lungs is antigen-independent and based solely on inflammatory 
signals; however, the absolute number of cells which can be recruited is dependent on the 
number of antigen-specific memory T cells located in the periphery (365,368).  
 
H.3.3.3. Timing of the Memory T cell Response to Secondary Influenza Challenge  
 
It is suggested that TEM are more effective at controlling infections at the very early 
stages, especially outside of secondary lymphoid organs. However, if the infectious 
challenge is greater than the capacity of TEM to control, then new cells need to be recruited 
from the TCM population in the peripheral lymphoid organs (275).  
Secondary influenza-specific CTL responses arise approximately 2 days faster than 
the primary response (268). Following a secondary challenge with influenza virus, non-
proliferating memory CD8+TEM in the lung airways are able to respond to initial viral loads 
(364,365). These cells are not able to clear virus completely since they are rapidly 
eliminated by apoptosis during the resultant inflammatory response, but can significantly 
reduce viral loads at early time points. Circulating TEM are then recruited to the lung airways 
by inflammatory signals and start trafficking to the lung and increase in number by day 2 
post infection. Since neither airway resident nor circulating TEM can proliferate and provide a 
sustained response, resolution of viral infection is dependent on the recruitment of 
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proliferating TEM generated from TCM in the lymphoid organs. Proliferating effector cells 
generated from TCM then dominate the later response to clear the infection. These cells have 
been restimulated with antigen and proliferate in the spleen, draining LN and lung 
parenchyma before entering the circulation and being recruited to the lung airway around 
day 4 post infection and peaking around day 7 (369).  
There is some evidence that DC interaction is important for activating this phase of 
CD8+ memory response; however, requirements for costimulation are considerably lower  
that of naïve precursors (302,370). Following infection, numbers of effector T cells decline, 
resulting in memory cell generation and the replacement of the original resident CD8+ 
memory cells by circulating memory cells which continue to enter the airway after the 
resolution of inflammation (371). It is apparent that the temporal nature of the recall 
response is highly dependent on both inflammatory signals and relative numbers of 
available memory cells. Early response to virus is dependent on airway resident TEM to 
initiate antiviral response as well as TEM recruited from circulation by the resultant 
inflammatory signals.   
 
H.3.4. Memory T cell Survival and Maintenance 
 
Requirements for T cell survival and proliferation differ depending on the maturation 
and activation state of the T cell itself. Following clearance or containment of a pathogen, 
90-95% of antigen-specific cells die, probably via “neglect” because of loss of contact with 
the common cytokine-receptor γ-chain (γc) family of cytokines and/or TCR signals (372-374). 
In order to provide protection, it is important to maintain a population of antigen-specific 
memory T cells capable of responding following exposure to the same or similar pathogens. 
Memory CD8+ T cells have been found to survive long term in both mouse (>2 years) and 
human (>50 years) populations (375,376). Originally, it was thought that low levels of 
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antigen were responsible for the maintenance of a viable memory cell pool.  It is now 
apparent that antigen is not needed for the persistence of memory T cells and that memory 
T cells continue to divide at a slow rate in the absence of antigen (283,373,375). Two 
members of the γc cytokine are particularly important for antigen-specific CD8
+ memory T 
cells. IL-7 and its respective receptor, IL-7Rα (CD127) are related to memory T cell survival 
while IL-15 and its receptors govern the intermittent homeostatic proliferation necessary for 
maintaining a population of memory T cells (377,378). 
  
H.3.4.1. IL-7/CD127 (IL-7Rα) 
 
IL-7 signaling appears to be important for the long-term survival of antigen-specific 
memory T cells (379). IL-7 binds to the receptor consisting of the high-affinity IL-7R alpha 
chain (IL-7Rα) and the γc chain (373,374,380). Expression of IL-7Rα has been directly linked 
to the memory precursor effector population and maintenance of IL-7Rα expression during 
infection leads to greater propensity to join the memory T cell pool. In terms of survival, 
abrogation of IL-7Rα expression results in decreased memory T cell persistence (381,382). 
The requirement of IL-7Rα signaling for the survival of antigen specific memory T cells is 
tied to the regulation of downstream antiapoptotic signaling molecules. Binding of IL-7 to its 
receptor results in the activation of the JAK-STAT pathway. Notably the activation of JAK1, 
JAK3 and STAT5 is followed by the upregulation of the antiapoptotic molecule Bcl-2. Bcl-2 
leads to enhanced cell survival by inhibiting the pro-apoptotic protein Bcl-2-interacting 
mediator of cell death (BIM). Expression of IL-7Rα is dynamically regulated by cytokines 
and TCR signaling. Prosurvival cytokines such as IL-2, IL-6, IL-7 and IL-15 can suppress the 
expression of IL-7Rα while expression of cytokines with anti-proliferative or proapoptotic 
properties, such as IFN-α/β and TNFα may upregulate IL-7Rα on T cells to enhance their 
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survival (378,383). Additionally, differential expression of IL-7Rα is regulated on the genetic 
level with various transcriptional factors and epigenetic mechanisms regulating IL7Ra gene 
expression. (384,385).  
 
H.3.4.2. IL-15/CD122 (IL-2/15Rβ) 
 
IL-15 is an essential γc cytokine that induces the regulation of slow, intermittent basal 
homeostatic proliferation of antigen-specific CD8+ memory T cells (379). Viral challenge of 
IL15-/- and IL-15Rα-/- mice show that IL-15 is dispensable for the generation of antigen-
specific CD8+ memory T cells; however, the memory T cell pool decreased over time 
(386,387). In IL-15-/- mice, bystander proliferation fails to occur. Wildtype memory CD8+ T 
cells transferred into these mice fail to proliferate and disappear rapidly (388). 
Overexpression of IL-15 increased the numbers of memory CD8+ cells (389,390). These 
results indicate that IL-15 is not necessary for the generation of memory CD8+ T cells but it 
is required for the homeostatic proliferation to maintain populations of memory cells over a 
lifetime. The IL-15 receptor (IL-15R) consists of high-affinity IL-15Rα, IL-2/15Rβ and γc 
subchains. These form a heterotrimeric receptor complex. Since IL-15 and IL-2 share 
signaling receptor subunits, IL-15 signaling is similar to that induced by IL-2. IL-15 binding to 
the complex IL-2/I5Rβ (CD122) and γc induces activation of Jak1/4-STAT5, PI3K/Akt and 
Ras/Raf/MAPK pathways in lymphocytes. These pathways induce cell proliferation and 
augment the effector functions of lymphocytes. It must be noted that IL-15, unlike Il-2, 
mediates these diverse signaling pathways dependently on cell type and on activation status 
of the responding cells (Budagian, Bulanova, Paus, 2006). Memory CD8+ T cells express 
high levels of CD122. In fact, antigen-experienced memory T cells upregulate CD122, 
whereas surface expression of CD122 is undetectable on naïve CD8+ T cells (391,392).  
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I. Obesity and Cell-mediated Immune Memory 
 
Reduction in the ability to generate and maintain functional influenza-specific memory T 
cells in a large portion of the obese population could greatly magnify the numbers of 
complications and deaths during a pandemic year.  
 
I.1. Obesity and Memory CD8+ T cell Generation and Function 
 
Diet-induced obesity in mice has been shown to alter dendritic cell steady state 
number and function (196,393). Additionally, antigen presentation by dendritic cells is 
impaired in obese animals (200). Since exposure to antigen is so important for memory cell 
generation, decreased DC function or numbers could lead to altered CD8+ T cell priming. 
Differential expression of CD62L has been observed in obese versus lean patients. Morbidly 
obese subjects downregulate CD62L expression on neutrophils which may affect the ability 
of these cells to activate and migrate to sites of potential infection (394). Depressed 
expression of CD62L may affect both initial response, resulting in altered memory 
generation or it could directly affect memory populations, decreasing the numbers of central 
memory phenotype cells available for recruitment. It is important to note that the early 
phases in the memory response are able to reduce the levels of viral amplification until the 
proliferative phase of the response generates a sustained supply of new effector cells  
(352). Reduction of either the function or number of  either TEM or TCM in the obesigenic 
environment could lead to the inability to mount an improved secondary response. 
Obesity has also been associated with a low-grade inflammatory state which has 
been implicated in the development of several obesity-associated disease states such as 
type 2 diabetes mellitus and atherosclerosis (395) . Current research of adipose tissue as an 
endocrine organ has also added to this theory, demonstrating its ability to secrete 
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inflammatory mediators such as TNF-α and IL-6 (396,397). Increased obesity and/or 
adiposity in humans has been associated with increased serum levels of CRP, TNF-α, IL-6 
and IL-18 and these cytokines have been shown to decrease after weight loss and 
moderate exercise (398-404). Inflammation is also altered during infection in the obese host 
(199). The possibility of a chronic inflammatory state as well as greater expression of 
inflammatory mediators during infection could tip the balance of memory cell generation, 
pushing development towards a greater number of primary effector CTL and diminished 
memory cell precursors.   
Additionally, since the lung maintains tight control over T cell function in the airways, 
the inflammatory state associated with obesity may alter the ability to respond to a 
secondary infection. Any disturbance in this balance of regulation could alter the memory 
response of influenza-specific CD8+ T cells during secondary challenge. 
 
I.3. Obesity and Memory CD8+ T cell Maintenance 
 
As discussed previously, IL-7 and IL-15 have clearly been found to promote T-cell 
immunity. Aberrant production of these cytokines could cause harm or dysregulate the 
maintenance/survival of memory CD8+ T cells. Little is known about the association of IL-15 
and IL-7 and obesity. In terms of adipose tissue, IL-15 is produced by the skeletal muscle 
and has been found to greatly affect lipid metabolism. It is hypothesized that IL-15 is 
released from the skeletal muscle with the aim of controlling fat deposition (405,406).  IL-7 
may be secreted by adipose tissue and, therefore, upregulated in obesity (407). It is 
important to note that NK cells are highly dependent on IL-15 for survival, which may be of 
note since NK function was decreased in our diet-induced obese mice (408). Any alterations 
in these maintenance cytokines could cause a dysregulated recall response in obese 
animals. 
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J. Conclusions 
 Generation, function and maintenance of a protective population of antigen-specific 
memory T cells are highly dependent on a concert of a number of complex interactions 
occurring during a primary immune response. Altering the balance of this primary response, 
such as we see in the obese state, could greatly impact the subsequent protective capacity 
of the resultant antigen-specific memory T cell pool. Both obesity and influenza pose 
significant public health threats. Therefore, this work aims to determine the impact of obesity 
on  the generation, function and maintenance of influenza-specific memory T cells in an 
obese host. 
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A. ABSTRACT 
 
The CDC has suggested that obesity may be an independent risk factor for 
increased severity of illness from the H1N1 pandemic strain. Memory T cells generated 
during primary influenza infection target internal proteins common among influenza viruses, 
making them effective against encounters with heterologous strains.  In male, diet-induced 
obese C57Bl/6 mice, a secondary H1N1 influenza challenge following a primary H3N2 
infection led to a 25% mortality rate (with no loss of lean controls), 25% increase in lung 
pathology, failure to regain weight and 10 to 100 fold higher lung viral titers. Furthermore, 
mRNA expression for interferon γ (IFN-γ) was >60% less in lungs of obese mice along with 
one third the number influenza-specific CD8+ T cells producing IFN-γ post secondary 
infection versus lean controls. Memory CD8+ T cells from obese mice had a >50% reduction 
in IFN-γ production when stimulated with influenza-pulsed dendritic cells from lean mice. 
Thus, the function of influenza-specific memory T cells is significantly reduced and 
ineffective in lungs of obese mice. The reality of a worldwide obesity epidemic combined 
with yearly influenza outbreaks and the current pandemic makes it imperative to understand 
how influenza virus infection behaves differently in an obese host. Moreover, impairment of 
memory responses has significant implications for vaccine efficacy in an obese population. 
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B. INTRODUCTION 
 
Obesity has become a worldwide epidemic. The World Health Organization (WHO) 
predicts that by the year 2015, 2.3 billion adults will be overweight (BMI ≥ 25) with 700 
million being classified as clinically obese (BMI ≥ 30) (1). Obesity has been linked to 
numerous health problems and chronic diseases, including type 2 diabetes, hypertension, 
dyslipidemia, certain cancers, and cardiovascular diseases (10). These co-morbidities have 
been associated with hormonal and metabolic changes related to an increase in adipose 
tissue mass (14). Obesity has been well established as a risk factor for increased morbidity 
and mortality; however, its effects on susceptibility to infection are just beginning to be 
understood. In the hospital setting, obese patients are more likely to develop secondary 
infections and complications such as sepsis, pneumonia, bacteremia and wound and 
catheter-related infections. Patients with increased BMI and adiposity also present a higher 
incidence of surgical site infections, which have been associated with increased risk of other 
wound complications, increased length of stay and increased risk of death (166-
168,170,171). Obesity also negatively affects pulmonary function and BMI has been 
correlated to increased susceptibility to community-related respiratory tract infections 
(21,172,174,175).   
Influenza is a seasonal respiratory illness caused by the influenza virus. Spread 
through airborne transmission, these viruses are highly contagious and are responsible for a 
great deal of morbidity and mortality in the world (201). In any given year,  5-15% of the 
world population is infected with influenza virus resulting in 3-5 million cases of severe 
illness and 500,000 deaths from influenza and influenza-related complications (202). Young 
children, the elderly and people with chronic diseases are particularly susceptible to 
influenza-related complications and mortality (203). Influenza viruses undergo continual 
mutation (drift) in surface antigens and occasional gene reassortment (shift) resulting in 
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heterologous strains with serologically distinct surface proteins. Therefore, a vaccine which 
promotes a robust memory B cell antibody-based response to the surface proteins of one 
strain of influenza could be ineffective for a strain encountered the next season expressing 
different surface proteins (267). By comparison, memory T cells generated during primary 
influenza infection can target internal proteins common and less variable among influenza 
strains, making them more effective against encounters with heterologous virus stains (268).  
Very recently, the CDC has suggested that obese individuals are at a greater risk of 
morbidity and mortality from pandemic novel influenza H1N1 strain. Speculation on the 
cause ranges from excess adipose tissue constricting lung volume to chronic inflammation 
influencing the immune response (205). We hypothesize this increased severity may be due 
to obesity decreasing memory cell-mediated defenses against heterosubtypic influenza 
infection. Previously, we demonstrated that influenza infected diet-induced obese (DIO) 
mice developed increased lung pathology, decreased expression of IFNα/β and delayed 
expression of pro-inflammatory cytokines and chemokines (199). In addition, dendritic cells 
(DC) from obese mice failed to efficiently present influenza antigen to T cells (200). Because 
development and subsequent functionality of T cell mediated immune memory depends on 
the primary response (283), we hypothesized that obese mice would have an impaired 
memory T cell response to a secondary influenza infection. 
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C. MATERIALS AND METHODS 
 
Animals.  
Weanling, male C57BL/6J mice were obtained from Jackson Laboratories (Bar 
Harbor, ME, USA). All mice were housed at the University of North Carolina Animal Facility, 
which is fully accredited by the American Association for Accreditation of Laboratory Animal 
Care. Animals were housed 4/cage under pathogen-free/viral Ab-free conditions and 
maintained under protocols approved by the Institutional Animal Use and Care Committee. 
Mice were randomized to receive either a low-fat/no-sucrose diet or a high-fat/high-sucrose 
diet for 20 wk. The diets, previously described by Surwit et al.(50,409), were obtained from 
Research Diets (New Brunswick, NJ, USA). The low-fat diet (D12328) consisted of 16.4% 
protein, 73.1% carbohydrate (83% starch, 17% maltodextrin), 10.5% fat (38% soybean, 62% 
coconut oil).  The high-fat diet (D12331) consisted of 16.4% protein, 25.5% carbohydrate 
(51% sucrose, 49% maltodextrin), 58% fat (93% coconut oil, 7% soybean oil). Previous 
studies in our lab (199) and others(410,411) have confirmed that these diets result in 
significant diet-induced obesity (increased body weight, increased body fat mass) in these 
mice. This induction of obesity had also been shown to be reversed in these animals by 
switching from high to low-fat diet (411). 
 
Influenza viruses and infection.  
Mouse-adapted influenza virus strain X-31 (H3N2) (a generous gift from David 
Woodland, Trudeau Institute, Saranac Lake, NY, USA) and A/Puerto Rico/8/34 (PR8, 
American Type Culture Collection, Manassas, VA, USA) were grown in the allantoic fluid of 
embryonated hen’s eggs. Created by Edward Kilbourne (1969), influenza X-31 is a mouse-
adapted recombinant influenza virus consisting of the external hemagluttanin (HA) and 
neuramidase (NA) proteins of A/Aichi/2/68 (H3N2) and the internal proteins of A/Puerto 
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Rico/8/34 (H1N1) (412). The X-31 strain is sublethal and efficient at producing memory T 
cells which are able to fight a secondary A/PR/8 infection (413). For primary infection, lean 
and obese mice were anesthetized i.p. with ketamine/xylazine and subsequently inoculated 
intranasally with 300 EID50 live X-31 virus in 0.03 mL sterile PBS. Thirty one days post 
infection (p.i.), no X-31 virus was detected by qRT-PCR or TCID50 in mouse lungs (n=8) in 
either lean or obese mice. Mice were then challenged at 31 days post X-31 infection 
intranasally with a secondary infection of 5000 TCID50 (100x LD50 in lean mice during a 
primary infection) live PR8 virus in 0.05 mL sterile PBS. 
 
Lung histopathology:  
As previously described (414), lungs were removed at d 10 p.i. and perfused with 
Optimal Cutting Temperature Compound (Tissue-Tek, Torrance, CA, USA) and frozen on 
dry ice. Frozen sections (6µm) were stained with hematoxylin and eosin. The extent of lung 
pathology was graded in a semiquantitative manner according to the relative degree (from 
lung to lung) of mononuclear cell infiltrate. Briefly, The scoring is on a scale from 0 to 4: 0- 
no inflammation, 1-mild influx of inflammatory cells, 2-increased inflammation with 
approximately 25-50% of the total lung involved, 3-severe inflammation involving 50-75% of 
the lung and 4-almost all lung tissue contains inflammatory infiltrates. 
 
Quantitation of viral titers in lungs:  
Lung viral titers were determined by a modified tissue culture infections dose 50 
(TCID50) using hemagglutination as an endpoint,
 as previously described (199). Briefly, half 
of the right lobe of the lung was removed, weighed, and ground in 0.2 mL minimal essential 
medium (MEM). Samples were centrifuged at 9000 x g for 20 min and the supernatant was 
serially diluted starting at 1:10 in MEM containing 20 mg/L trypsin. Each diluted supernatant 
(0.1 mL) was added, in duplicate, to 80% confluent Madin-Darby canine kidney cells and 
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incubated at 37°C for 96 h. A 0.5% suspension of human O RBC (0.05 mL) was added to 
each well and incubated at room temperature for 2 h. TCID50 was determined by the method 
of Reed and Muench (415). Values were normalized to weight of the original tissue used. 
 
Quantitation of lung mRNA cytokine levels:  
Lung samples were collected on d 0 (uninfected), 1, 2, 3, 7 and 10 p.i. and total RNA 
was isolated using the TRIzol method. Reverse transcription was carried out with 
Superscript II First Strand Synthesis kit (Invitrogen, Carlsbad, CA, USA) using oligo (dT) 
primers. Following previously described methods (199), mRNA levels for murine interferon 
IFNα, IFNß, IFN-γ, IL-6, and TNFα, and G3PDH were determined using quantitative real 
time polymerase chain reaction (qRT-PCR).  
 
Isolation of cells from the lungs and spleen:  
As previously described (200), lungs from lean and obese mice were removed, 
digested in HBSS (with calcium and magnesium) supplemented with 160 U/mL Collagenase 
type 1 (Worthington, Lakewood, NJ, USA). Spleen cells were isolated in unsupplemented 
HBSS. Samples were processed into single-cell suspensions by mechanical agitation of a 
Stomacher (Seward, West Sussex, UK) and strained through a 40-µm nylon filter. Cells 
were subjected to red blood cell lysis using ACK lysis buffer for 5 min at room temperature, 
washed, counted then subjected to analysis by flow cytometry.  
 
Flow Cytometry:  
At least 1 x 106 cells were stained with fluorescein isothiocyanate (FITC)-anti-CD44, 
Pacific Blue-anti-CD62L (both from eBioscience, San Diego, CA, USA) and peridinin-
chlorophyll-protein complex (PerCP)-anti-CD8α (BD Biosciences, San Jose, CA, USA). 
CD8+ T cells specific for the major epitope of the PR8 nucleoprotein were identified using a 
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phycoerythrin (PE)-labeled DbNP366-374 tetramer. Non-specific tetramer staining was 
analyzed using an irrelevant tetramer towards herpes simplex virus. Intracellular staining 
was performed on total lung cells from influenza-infected mice that were incubated for 4 hr 
with GolgiPlug (BD Biosciences, San Jose, CA, USA). Cells were then Fc-blocked with anti-
CD16/CD32, surface stained, and permeabilized with Perm/Wash (BD Biosciences, San 
Jose, CA, USA) for staining with allophycocyanin (APC)-anti-IFN-γ. An irrelevant APC-
immunoglobulin G (IgG) was used as a staining control. For dendritic cells, samples were 
stained with FITC-anti-CD11b and eFluor 450-anti-CD11c (eBioscience, San Diego, CA, 
USA). Samples were analyzed on a Cyan ADP flow cytometer (Beckman Coulter, Fullerton, 
CA, USA) and data was analyzed using FlowJo software (TreeStar, San Jose, CA, USA). 
Gates were set for DC based on previous reports (200,416,417). Briefly, gates were set 
based on CD11b and CD11c expression and DC were determined by intermediate levels of 
CD11b and CD11c. 
 
Antigen presentation by dendritic cells:  
Using previously published methods(200), lungs from lean and obese mice infected 
31 days previously with influenza X-31 were removed and processed into single cell 
suspensions as described above. Lung isolates were then pooled into groups of 3 mice 
based on diet. To isolate as many dendritic cells as possible, cells were resuspended in 
Ca2+ and Mg2+ free HBSS containing 10 mM EDTA and incubated at room temperature with 
agitation for 5 min.  Cells were counted using a hemocytometer and 5 x 107 cells were used 
to isolate DC from each pool using a DC enrichment kit (Invitrogen Dynal AS, Oslo, 
Norway). T cells were isolated from a separate group of lean and obese mice previously 
infected with influenza X-31. Pooled suspensions as described above were isolated using a 
T cell negative isolation kit (Invitrogen Dynal AS, Oslo, Norway). DC were incubated with 
heat-inactivated influenza A/PR/8 at an MOI of 2 for 2 hours followed by extensive washing 
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to remove excess virus. DC were plated with T cells in a 96-well plate at a DC to T cell ratio 
of 1:2. Samples were then incubated for 2 h at 37oC followed by the addition of Golgi Plug 
(BD Biosciences) and incubated for an additional 4 h. Cells were stained with anti-
CD16/CD32, FITC-anti-CD3 and PerCP-Cy5.5-anti-CD8 (eBioscience, San Diego, CA, 
USA) followed by fixation and permeabilization for subsequent intracellular staining with 
APC-anti-IFNγ. Cells were run on an Accuri C6 flow cytometer  (Accuri, Ann Arbor, MI, USA) 
and samples were analyzed using FlowJo software (TreeStar, San Jose, CA, USA). 
 
Serum leptin was measured using a commercially available ELISA (R&D Systems, 
Minneapolis, MN, USA). 
 
Statistical Analysis.  
Statistical analyses were performed using JMP Statistical Software (SAS Institute, 
Cary, NC, USA). Nonparametric data were analyzed using Kruskal Wallis test (α=0.05). 
Normally distributed data were analyzed by 2-way ANOVA with diet and day post infection 
as main effects. Student's t test was used for post-hoc comparison between the dietary 
groups and Tukey's HSD was used for post-hoc comparisons among the days p.i. 
Differences were considered significant at p < 0.05. 
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D. RESULTS 
 
DIO mice have increased morbidity and mortality when challenged with a secondary 
influenza infection.  
To test the effect of obesity on influenza-specific cell mediated immunity, lean (35.7 ± 
0.4g) and obese (52.2 ± 0.4g) mice were primed with the recombinant influenza X31 strain 
(H3N2), followed by a dose of influenza A/PR/8/34 (PR8; H1N1) strain 4 weeks later which 
is normally lethal in naïve mice. Primary and memory T cell response experiments can be 
conducted with mouse-adapted X-31 and PR8 because they differ in surface protein 
expression, thus minimizing antibody mediated clearance of secondary infection (341). By 
day 7 post PR8 challenge, 25% of the obese mice had died with no loss of lean controls 
(Fig. 1A).Consistent with infection, both groups lost weight following PR8 challenge, 
although the infection was more severe in the obese mice as indicated by the lack of weight 
regain (Fig. 1B). This increased severity of infection was confirmed by the increased lung 
pathology (Fig. 2A and 2B) and viral titers (Fig. 2C) in obese mice.  
 
DIO alters antiviral cytokine expression in the lungs following secondary challenge.  
Respiratory epithelial cells are a primary target of influenza virus and play an 
important role in the pathogenesis of influenza infection. Infection of respiratory epithelial 
cells with influenza virus results in activation of retinoic acid-inducible gene-I and Toll-like 
receptor 3 which then signal to begin production of IFN-α and IFN-β (418,419). These key 
cytokines function to control viral replication as well as induce both the innate response and 
the subsequent generation of the adaptive immune response (420-422). Concordant with 
our observations of primary influenza infection in obese mice (199), lean mice had a robust 
increase in IFNα/β mRNA expression at day 2 post secondary challenge; however, obese 
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mice had no increase in IFNα and the increase in IFNβ expression was significantly reduced 
versus lean controls (Fig. 3).  
 
Obesity reduces the ability of the mice to produce a proinflammatory response post 
secondary infection.  
Obesity leads to a low-grade inflammatory state (423) resulting in increased serum 
levels of TNF-α and IL-6 which are reversed by weight loss and moderate exercise 
(398,424-426). Although obesity leads to an inflammatory state in the serum, we also show 
that the lungs of obese mice were in a state of elevated inflammation even before secondary 
challenge (Fig. 4A). It is possible that because of this increased inflammatory state of the 
lungs, obese mice challenged with a secondary influenza infection failed to upregulate lung 
mRNA expression of inflammatory cytokines Interleukin (IL)-6 (Fig. 4B) and tumor necrosis 
factor α (TNFα) (Fig. 4C) resulting in a significantly blunted response relative to lean 
controls.  
 
IFN-γ expression is significantly reduced in the lungs of DIO mice following 
secondary challenge.  
Following a secondary challenge with influenza virus, non-proliferating memory CD8+ 
T cells in lung airways are able to respond to viral replication by generating inflammatory 
signals to induce the antiviral response(364,365). These cells cannot clear virus completely, 
but can significantly reduce viral loads through IFN-γ production at early time points. DIO 
mice had significantly reduced expression of INF-γ mRNA in the lungs at d 1, 3 and 7 post 
secondary challenge (Fig. 5A). Although the overall percentage of memory T cells did not 
differ between mice (Fig. 5B), percentage of  influenza-specific effector memory T cells 
(CD8+/DbNP366
+/CD44+/CD62L-) producing IFN-γ  was reduced in DIO mice at day 5 (Fig. 
72 
 
5C). In addition, the numbers of influenza-specific effector memory T cells producing IFN-γ 
at d 5 post secondary challenge was significantly reduced with less than half the total 
numbers responding in obese mice versus lean (Fig. 5D). Mean fluorescence intensity of 
IFN-γ production was significantly reduced in obese mice, further indicating a functional 
difference (Fig. 5E).  
 
Diminished capacity of lung-resident memory T cells from obese mice to respond to 
influenza-specific antigen presentation.  
Despite reduced percentage (Fig 6A) and number (Fig. 6B) of DC in the lungs of 
obese mice, obese DC were able to present antigen effectively to lean memory T cells ex 
vivo (Fig 6C).  In contrast, obese memory T cells, when stimulated with lean DC, were less 
able to respond to antigen presentation with a >50% reduction in IFN-γ producing cells (Fig. 
6C).  
 
Obesity leads to an altered serum leptin profile post secondary infection.  
Leptin has been identified as an important immunomodulatory molecule for both the 
innate and adaptive response. Indeed, leptin is produced at high levels during inflammation 
and is involved in a number of immune pathways and cell types (165). As previously 
demonstrated (427,428), serum leptin levels are significantly elevated in diet-induced obese 
mice. In lean mice, leptin levels are significantly elevated post infection, however this 
response did not occur in the obese mice (Fig 7). 
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D. DISCUSSION 
 
To our knowledge, this is the first time that diet-induced obesity has been shown to 
affect the memory response to a viral infection. It is apparent that diet-induced obesity 
results in an ineffective memory response to influenza infection impacting both memory T 
cell function and reducing the DC population in the lung. The protective effect of memory T 
cell populations against influenza infection has been shown in a number of models including 
against the highly pathogenic H5N1 viruses (344). Prime-challenge with a H9N2 isolate was 
protective against A/Hong Kong/156/97 (345) and a double-priming with both X-31 and PR8 
was protective against one of the most lethal H5N1 strains (268).  Indeed, in our study, 
protection against a heterologous strain of influenza was observed in the lean mice with 
100% survival against a lethal dose of PR8 following X-31 priming; however, obesity 
reduced this protective capacity. Early innate antiviral cytokines IFNα and IFNβ were 
significantly delayed and reduced in the lungs of obese mice which may have contributed to 
the higher viral titers and increased infiltrate found in lungs of obese mice. IFNα/β 
expression has also been associated with immune memory generation and function and 
with a direct signal from IFNα/β required for memory T cells to survive the contraction phase 
of the primary response (429,430). 
During the course of an influenza virus infection, heterogeneous pools of persistent 
memory CD8+ T cells are established. Influenza-specific CD8+ T cells have been observed 
in both humans and animal models months to years post influenza infection (346-348). A 
significant number of memory cells can be found in secondary lymphoid organs such as the 
draining lymph nodes and spleen; however, as many as half of the influenza-specific CD8+ 
memory T cells can be found in peripheral (nonlymphoid) organs (341,346,431). When 
functioning properly, populations of memory T cells serve not to prevent viral infection but to 
reduce the level of viral amplification until a sustained supply of new effector cells can be 
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generated (352). Reduction of either the function or number of these cells could lead to the 
inability to mount an efficient secondary response. Based on the increased morbidity and 
mortality seen in obese mice, along with the reduced effector function of obese influenza-
specific memory T cells versus the lean controls, it is clear that DIO mice have a significantly 
reduced capacity to respond to a novel influenza virus strain. 
The exact mechanism by which T cell memory develops remains controversial; 
however, the main consensus appears to be an adequate/balanced primary response. 
Development of a functionally protective CD8+ memory response depends on the integration 
of multiple signals both by responding T cells and by other immune mediators such as 
antigen presenting cells (APC). Antigen density and time of contact with APC, levels of 
inflammatory cytokines and overall primary effector response all play a role in programming 
the development of effective memory T cell responses (283). The reduced protective 
capacity of the memory response in obese mice could be caused by defects in a single or 
combination of factors during the primary response.  
 APC depend on inflammatory signals for potent stimulation of T cell responses; 
however, it has become clear that T cells also receive signals from inflammatory cytokines. 
In the obese host, inflammation is altered during infection. We have shown inflammatory 
signals are delayed but increased in obese mice during primary  influenza infection (199). 
The amount of inflammatory signals received appears to balance effector and memory 
generation in primary CD8+ T cells. Higher levels of inflammatory cytokines indicate the 
need for a stronger initial response, which may lead to lowered memory generation (295). 
During primary influenza infection, we observed an increased antigen-specific T cell 
response (200), potentially resulting in decreased memory T cell generation. This chronic 
inflammatory state, as well as greater expression of inflammatory mediators during the 
primary infection, could tip the balance of memory cell generation to a “too much, too late” 
scenario. This scenario could push development towards greater generation of primary 
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influenza-specific effector T cells resulting in diminished numbers or function in memory cell 
precursors. 
CD8+ T cell responses have evolved to specifically eliminate pathogens and to 
protect against reinfection (271,272). During infection with PR8, lack of CD8+ cells results in 
decreased viral clearance and eventual morbidity (273,432). Antigen-specific memory T 
cells are protective since they are present in higher numbers than naïve precursors and 
respond rapidly upon reencounter with pathogen (433). Secondary influenza-specific T cell 
responses arise approximately 2 days faster than the primary response and have greatly 
increased activity and effector function (268). Following a secondary challenge with 
influenza virus, memory CD8+ T cells in the lung airways respond to initial viral loads by 
generating signals, such as IFN-γ, to induce the antiviral response (364,365). The protective 
value of CD8+ T cell memory cells is strongly correlated to the ability to exert effector 
function at the site of infection (366). Reduction in the relative number of memory T cells in 
the lung airways has been correlated to a decline in the overall recall response to viral 
challenge (346,367). DIO mice had decreased overall IFN-γ mRNA expression in the lung, 
as well as decreased percentage and overall number of influenza-specific effector memory 
T cells producing IFN-γ post secondary challenge. These data indicate a significant 
reduction in the ability of influenza-specific T cells in the lungs of obese mice to respond to a 
heterogeneous viral strain. 
The decreased production of IFN-γ by memory T cells during secondary infection in 
DIO mice may be due to impairment in DC function, as we previously demonstrated during 
primary influenza infection in DIO mice (200). Interestingly, we found that in contrast to a 
primary influenza infection, DC from DIO mice were able to efficiently present antigen to 
lean and obese memory T cells. There is some evidence that DC interaction is important for 
activating the CD8+ memory response; however, requirements for costimualtion by DC are 
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considerably lower that that of naïve precursors which may explain why obese DC were able 
to stimulate lean memory T cells (302,370). Additionally, reduction in the number of 
influenza-specific T cells may indicate an impairment of memory T cells to migrate to the 
obese lung microenvironment. Tissue-specific homing of memory cells allows for increased 
efficiency of adaptive response by providing increased numbers of antigen-specific T cells at 
the anatomical site most likely for reinfection (360). A similar situation could be associated 
with the reduction in the number of DC from the obese lung versus lean controls. 
Although the mechanistic link between obesity and diminished immune memory is 
not clear, a main factor which ties together obesity, inflammation and immune cell function is 
leptin resistance associated with the obese state. Leptin is recognized as an important 
mediator of immune function (434) and leptin expression is increased proportionately with 
adipose tissue mass, resulting in increased circulating levels in obesity (435). This chronic 
elevation appears to cause a state of leptin resistance in obese mice where leptin signaling 
is attenuated despite increased circulating levels (436).  Leptin signaling is important for 
virtually all parts of the innate immune response including antiviral (IFNα/β) cytokine 
expression, proinflammatory IL-6 and TNFα expression, and activation and stimulation of 
monocytes, DC and macrophages (150,437). Leptin also modulates adaptive immunity by 
increasing DC function and stimulatory capacity, promoting a TH1 response and enhancing 
T cell survival and proliferation (76,153,438,439). Leptin resistance has been found to 
negatively impact T cell responses as well as DC maturation and survival in obese mice 
(75,438,440). In this experiment, we have observed effects consistent with leptin resistance. 
Indeed, serum leptin was significantly increased in obese mice before secondary challenge 
and did not show an infection associated response as seen in the lean controls. Therefore, 
leptin resistance in obese mice may contribute to the reduced protective capacity of the 
memory response to secondary influenza infection. 
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The ability to generate functional memory T cells, either during primary infection or 
by vaccination, has proven to be protective against potentially lethal influenza strains 
exhibiting completely different surface antigens (268). The CDC and WHO have declared 
the currently circulating novel H1N1 influenza strain to be pandemic and obesity appears to 
be an independent risk factor for illness severity (205). Here we have demonstrated that 
increased morbidity and mortality during a secondary influenza infection in DIO mice is due 
to impairment in the ability to generate and maintain functional influenza-specific memory T 
cells. This finding, if applicable to a human obese population, has significant public health 
implications including current vaccine strategies which may be less effective in an 
increasingly obese population. 
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Figure 2.1. Morbidity and mortality in lean and obese mice during memory response 
to influenza infection. Following primary infection with influenza X-31, lean and obese mice 
were challenged with a dose of influenza PR8 normally lethal to lean, naïve mice. (A) Lean 
mice had 100% survival whereas obese mice had a 25% mortality rate by d 7 pi. (B) Obese 
mice fail to regain weight following secondary infection (n=12-24/group) ± SEM. *p<0.05, 
lean versus obese. 
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Figure 2.2. Obese mice have increased viral titer and pathology post secondary 
infection.  (A and B) Obese mice had increased lung pathology at d 10 pi (n=10/group). 
Data are expressed as mean ± SEM. *p<0.05, lean versus obese. (C) Obese mice had a 
greater than 10 fold increase in viral titer in the lungs at d 1, and 3 post infection following 
secondary PR8 challenge. No virus was detected (ND = not detected) before PR8 infection 
(d 0). The dashed line indicates the limit of detection for the assay. Data are representative 
of 3 separate experiments and are expressed as TCID50/mg lung tissue (n=3-4/group) ± 
SEM on a Log10
 scale. *p<0.05, lean versus obese. 
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Figure 2.3. Antiviral cytokine mRNA expression in the lung following secondary 
infection. mRNA expression of (A) IFNα and (B) IFNβ were measured in the lungs of lean 
and obese mice following secondary infection. Data are expressed by normalization to 
G3PDH values then to lean value at d 0 pi (n = 6-8 per group) ± SEM. There were no 
significant differences in G3PDH values. *p<0.05, lean versus obese. a – p<0.05 versus day 
0 of individual diet group. 
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Figure  2.4. Inflammation-associated cytokine mRNA expression in the lung prior to 
and following secondary infection.  (A) mRNA expression of IL-6 and TNFα were 
measured in the lungs of lean and obese mice before (d31 post X-31 infection) secondary 
infection. Data are expressed by normalization to G3PDH values (n = 6-8 per group) ± SEM. 
mRNA expression of (B) IL-6 and (C) TNFα  were measured in the lungs of lean and obese 
mice following secondary infection. Data are expressed by normalization to G3PDH values 
then to lean value at d 0 pi (n = 6-8 per group) ± SEM. There were no significant differences 
in G3PDH values. *p<0.05, lean versus obese. 
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Figure 2.5. IFN-γ expression in the lung following secondary infection is reduced in 
obese mice. (A) mRNA expression of IFN-γ was measured in the lungs of lean and obese 
mice following secondary infection using quantitative real time-PCR. Data are expressed by 
normalization to G3PDH values then to lean value at d 0 pi (n = 6-8 per group) ± SEM. 
There were no significant differences in G3PDH values. *p<0.05, lean versus obese. (B) 
Number of influenza-specific effector memory T cells (CD8+/DbNP366-374
+/CD44+/CD62L-) 
following secondary infection. (C) Percent of influenza-specific memory T cells at day 5 and 
(D) number of influenza-specific effector memory T cells producing IFN-γ. (E) Amount of 
IFN-γ produced by each cell using flow cytometry. Cells are gated as effector memory T 
cells (CD8+/DbNP366-374
+/CD44+/CD62L-) unless otherwise noted. No significant differences 
were observed in number of total cell numbers and total CD8+ T cell numbers between the 
lungs of lean and obese mice. Data are expressed as number or percent cells of total cells 
isolated and mean fluorescence intensity (n = 4-6 per group) +/- SEM. *p<0.05, lean vs 
obese. 
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Figure 2.6.  Impairment in function of memory T cells from the lungs of obese mice. 
(A) Percentage before secondary infection and (B) number of dendritic cells in the lungs of 
lean and obese mice following secondary challenge. Data are expressed as percentage and 
number of CD11b+/CD11cint cells of total cells isolated (n=6/group) ± SEM. *p<0.05, lean 
versus obese. (C) Ability of lean and obese DC to present antigen to lean T cells and obese 
T cells from lungs of influenza-experience mice. DC and T cells were isolated from lean and 
obese mice at d0 (d31 post X-31 infection). Data are expressed as # of CD3+/CD8+ cells 
producing IFN-γ+ as measured by flow cytometry (n=3/group/pool) ± SEM. *p<0.05, lean 
versus obese. 
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Figure 2.7.  Serum leptin concentrations for lean and obese mice following secondary 
challenge. Serum leptin levels measured by ELISA. Data as expressed as pg/mL (n=6-8 
per group) ± SEM. *p<0.05, lean versus obese. a – p<0.05 versus day 0.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER III 
 
INFLUENCE OF DIET-INDUCED OBESITY ON MAINTENANCE OF INFLUENZA-
SPECIFIC CD8+ MEMORY T CELLS 
 
Authors: Erik A. Karlsson, Patricia A. Sheridan, Melinda A. Beck 
 
Submitted: Journal of Nutrition 
 
 
A. ABSTRACT 
 
Obesity has been associated with increasing the risk for type 2 diabetes and heart 
disease, but its influence on the immune response to viral infection is under studied. 
Memory T cells generated during a primary influenza infection are important for protection 
against subsequent influenza exposures. Previously, we have demonstrated that diet-
induced obese mice have increased morbidity and mortality following secondary influenza 
infection compared with lean mice. To determine if the problem resided in a failure to 
maintain functional, influenza-specific CD8+ memory T cells, diet-induced obese (DIO) and 
lean mice were infected with influenza X-31. At 84 days post infection (p.i.), DIO mice had a 
10% reduction in memory T cell numbers. This reduction may be due to significantly 
reduced memory T cell expression of IL-2Rβ (CD122), but not IL-7Rα (CD127), which are 
both required for memory cell maintenance. Peripheral leptin resistance in the DIO mice 
may be a contributing factor to the impairment. Indeed, leptin receptor mRNA expression 
was significantly reduced in the lungs of obese mice while suppressor of cytokine signaling 
(SOCS)1 and SOCS3 mRNA expression were increased. It is imperative to understand how 
the obese state alters memory T cells as impairment in maintenance of functional memory 
responses has significant implications for vaccine efficacy in an obese population. 
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B.INTRODUCTION
 
Obesity is a major global public health problem. Although the humans are fairly well 
adapted to periods of reduced food intake, they are poorly adapted to overnutrition (8). 
Obesity can lead to serious health consequences and, subsequently, increases in health 
care requirements and economic burden. Caused by a change in energy balance of 
increased caloric intake versus expenditure (9), obesity has been linked to numerous health 
problems and chronic diseases (10,11). These co-morbidities associated with obesity have 
been attributed to hormonal and metabolic changes related to increases in adipose tissue 
mass (14,15). Obesity is an independent risk factor for cardiovascular disease, type 2 
diabetes, hypertension, arthritis, sleep apnea and cancer (17); however, its effects on 
susceptibility to infection are poorly understood.  In a hospital setting, obese patients are 
more likely to develop secondary infections and obese individuals are at increased risk for 
community-related respiratory tract infections (166,169,170,172). Studies in diet-induced 
obese animal models have shown obese mice had lower levels of mitogen-induced 
interleukin (IL)-2, although interferon (IFN)-γ and IL-4 production was increased (195). 
Additionally, obese mice have impaired dendritic cell (DC) function and altered T cell 
responsiveness (180-182,192,196,441,442). Very recently, the Centers for Disease Control 
and Prevention have declared that obese individuals are at a greater risk of morbidity and 
mortality from infection with pandemic novel influenza H1N1 strain. (205). At this time, it is 
unclear how obesity can result in a greater risk from H1N1 infection. 
Influenza is a highly contagious, seasonal respiratory illness caused by the influenza 
virus. In any given year, 5-15% of the world population is infected with influenza virus 
resulting in 3-5 million cases of severe illness and 500,000 deaths from influenza and 
influenza-related complications (201,202). Influenza viruses undergo continual mutation 
(drift) in surface antigens and occasional gene reassortment (shift) resulting in heterologous 
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strains with serologically distinct surface proteins. Therefore, a vaccine which promotes a 
robust memory B cell antibody-based response to the surface proteins of one strain of 
influenza could be ineffective for a strain encountered the next season expressing different 
surface proteins (267). By comparison, memory T cells generated during primary influenza 
infection can target internal proteins common and less variable among influenza strains, 
making them more effective against encounters with heterologous virus stains (268).  
Previously, we have shown that diet-induced obesity in mice significantly reduced the 
memory T cell response to secondary viral challenge resulting in increased morbidity and 
mortality (443). In order to understand how obesity contributes to a poor response to 
secondary viral challenge, we examined the ability of diet-induced obese mice to maintain 
influenza-specific memory CD8+ T cells. 
 
C. MATERIALS AND METHODS 
 
Animals.  
Weanling, male C57BL/6J mice were obtained from Jackson Laboratories (Bar 
Harbor, ME, USA). All mice were housed at the University of North Carolina Animal Facility, 
which is fully accredited by the American Association for Accreditation of Laboratory Animal 
Care. Animals were housed 4/cage under pathogen-free/viral Ab-free conditions and 
maintained under protocols approved by the Institutional Animal Use and Care Committee. 
Mice were randomized to receive either a low-fat diet (D12329) or a high-fat/high-sucrose 
diet (D12331) for 20 wk. The diets, previously described by Surwit et al. (50,409), were 
obtained from Research Diets (New Brunswick, NJ, USA). Previous studies in our lab (199) 
and others (410,411) have confirmed that these diets result in significant diet-induced 
obesity (increased body weight, increased body fat mass) in these mice.  
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Influenza viruses and infection.  
Mouse-adapted influenza virus strain X-31 (H3N2) (a generous gift from David 
Woodland, Trudeau Institute, Saranac Lake, NY, USA) was grown in the allantoic fluid of 
embryonated hen’s eggs. Created by Edward Kilbourne (1969), influenza X-31 is a mouse-
adapted recombinant influenza virus consisting of the external hemagglutinin (HA) and 
neuramidase (NA) proteins of A/Aichi/2/68 (H3N2) and the internal proteins of A/Puerto 
Rico/8/34 (H1N1) (412). The X-31 strain is sublethal and efficient at producing memory T 
cells which are able to prevent a lethal infection with a secondary A/PR/8 infection (413). For 
infection, following 20 weeks on the diets, lean and obese mice were anesthetized i.p. with 
ketamine/xylazine and subsequently inoculated intranasally with 300 EID50 live X-31 virus in 
0.03 mL sterile PBS. Mice were maintained on the diets. By day 33 pi, no virus was detected 
in the lungs of either lean or obese mice, demonstrating clearance of the infection (data not 
shown). 
 
Quantitation of lung and spleen mRNA cytokine levels 
 Lung and spleen samples were collected on d 33 and 84 p.i. and total RNA was 
isolated using the TRIzol method. Reverse transcription was carried out with Superscript II 
First Strand Synthesis kit (Invitrogen, Carlsbad, CA, USA) using oligo (dT) primers. 
Following previously described methods for quantitative real time polymerase chain reaction 
(qRT-PCR)(199), mRNA levels for murine interleukin (IL)-6, and TNFα and G3PDH were 
determined using previously described primer/probe sets and mRNA levels for IL-15 
(Mm00434210_m1), IL-7 (Mm00434291_m1), CD122 (Mm00434264_m1), ObR 
(Mm00440181_m1), SOCS1 (Mm00782550_s1), SOCS3 (Mm00545913_s1) and β-Actin 
(Mm01205647_g1) were determined using TaqMan Gene Expression Assays (Applied 
Biosystems, Foster City, CA). 
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Isolation of cells from the lungs, spleen and draining lymph node 
As previously described (200), lungs from lean and obese mice were removed and 
digested in HBSS (with Ca and Mg) supplemented with 160 U/mL Collagenase type 1 
(Worthington, Lakewood, NJ, USA). Spleen and draining lymph node (mediastinal) cells 
were isolated in unsupplemented HBSS. Samples were processed into single-cell 
suspensions by mechanical agitation of a Stomacher (Seward, West Sussex, UK) and 
strained through a 40-µm nylon filter. Cells were subjected to red blood cell lysis using ACK 
lysis buffer for 5 min at room temperature, washed, counted then analyzed by flow 
cytometry.  
 
Flow Cytometry 
At least 1 x 106 cells were stained with fluorescein isothiocyanate (FITC)-anti-CD44, 
Pacific Blue-anti-CD62L (eBioscience, San Diego, CA, USA) and peridinin-chlorophyll-
protein complex (PerCP)-anti-CD8α (BD Biosciences, San Jose, CA, USA). CD8+ T cells 
specific for the major epitope of the A/PR/8 nucleoprotein were identified using a 
phycoerythrin (PE)-labeled DbNP366-374 tetramer. Non-specific tetramer staining was 
analyzed using an irrelevant tetramer towards herpes simplex virus. Samples were analyzed 
on a Cyan ADP flow cytometer (Beckman Coulter, Fullerton, CA, USA) and data was 
analyzed using FlowJo software (TreeStar, San Jose, CA, USA).  
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D. RESULTS 
 
Diet-induced obese mice have significantly increased weight compared to lean 
controls.   
At d 33 post infection DIO mice weighed approximately 20 g more than their lean 
counterparts. At d 84 pi, lean mice had gained ~5 g of weight from d 33; however, lean mice 
still weighed approximately 15 g less than their DIO counterparts  (Figure 1). 
 
Influenza-specific central memory T (TCM) cells increase over time in the lung, spleen.  
 Following a primary influenza infection, a small population of influenza specific TCM  
cells remain in secondary lymphoid tissues, which includes the bronchiole-associated 
lymphoid tissue (BALT) of the lungs. In the lungs of both lean and obese mice, percent 
(Figure 2A) but not number (Figure 2B) of TCM cells increased over time. No difference was 
observed between the lean and obese groups. In contrast, while percent of TCM cells 
increased in the spleen of both groups over time (Figure 2C), at d 84 pi obese mice had a 
significantly increased number of TCM in the spleen compared to lean controls (Figure 2D). 
 
DIO mice maintain significantly reduced numbers of influenza-specific CD8+ effector 
memory T (TEM) cells in the lungs.  
 Following primary influenza infection, a population of influenza-specific TEM cells is 
maintained in the lung to more rapidly respond to the next encounter with an influenza virus. 
At d 33 post X-31 infection, both lean and obese mice had populations of influenza-specific 
TEM cells in the lung (Figure 3A). In both the lean and obese mice,  population percent and 
number of effector memory T cells declined over time; however, the DIO mice had a greater 
percent loss of  TEM cell numbers resulting in a significant decrease in TEM numbers in the 
lungs of obese mice compared to lean controls at d 84 pi (Figure 3B and 3C).  In the lymph 
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node and spleen, the number of TEM decreased over time in both the lean and obese mice; 
however, no difference was observed between the two dietary groups (data not shown). 
 
CD122 (IL-2Rβ) expression is significantly reduced on influenza-specific TEM cells in 
the lungs of obese mice.  
In both lean and obese mice, percentage of TEM cells expressing CD122 increased 
over time; however, at d 33 pi, percentage of TEM cells expressing CD122 was significantly 
reduced in the lungs of obese mice compared to lean controls (Figure 4A and 4B). In 
addition to reduced percentage of cells expressing CD122, mean fluorescence intensity of 
CD122 was also significantly reduced on TEM cells in the lungs of obese mice (Figure 4C). 
No differences were observed in the mRNA expression of CD122 in the lungs of obese mice 
versus lean controls (data not shown). 
 
Obese mice have altered expression of IL-15 and IL-7 mRNA in the lungs post primary 
infection.  
IL-7 and IL-15 are the cytokines responsible for the homeostasis and survival of 
memory T cells. In the lungs of obese mice, IL-15 mRNA expression at d 84 pi was 
approximately 3 times greater versus lean controls (Figure 5A). In contrast, expression of IL-
7 mRNA was decreased by 50% at d 33 in the lungs of obese mice versus lean controls. 
Interestingly, in both lean and obese mice expression of IL-7 mRNA significantly increased 
over time (Figure 5B). 
 
ObR expression is reduced and SOCS 1 and 3 expression is increased in the lungs of 
obese mice.  
In the lungs of obese mice, leptin receptor (ObR) mRNA expression was significantly 
less than in lean mice at both d33 and 84 p.i.  ObR expression increased in the lungs of lean 
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mice by d 84 post X-31 infection; however, expression was not found to increase in the 
lungs of obese mice (Figure 6A). Additionally, expression of SOCS1 (Figure 6B) and SOCS3 
(Figure 6C) was significantly increased in the lungs of obese mice at d 84 pi. 
 
The lungs of obese mice have significantly increased inflammation in the absence of 
viral infection.  
Following clearance of the X-31 infection at d 33 pi, mRNA expression of both IL-6 
and TNFα was significantly increased in the lungs of obese mice compared to lean controls. 
mRNA expression was still significantly increased at d 84 pi. 
 
E. DISCUSSION 
 
 A vaccine which promotes a robust memory B cell antibody-based response to the 
surface proteins of one strain of influenza could be ineffective for a strain encountered the 
next season expressing different surface proteins (267). However, there are several internal 
viral proteins that are highly conserved among influenza viruses, and therefore do not 
experience the mutations seen with the external proteins.  Although these internal proteins 
do not generate an effective antibody response because of their lack of accessibility to 
antibodies, the cell-mediated immune response can recognize these proteins. Therefore, 
memory T cells generated during a primary influenza infection can target these internal 
proteins common to influenza strains, making them effective against encounters with 
heterologous virus stains. The ability to generate functional memory T cells, either during a 
primary infection or by vaccination, has proven to be protective against potentially lethal 
influenza strains exhibiting completely different surface antigens (268). Following viral 
clearance, contraction of activated CD8+ T cells results in influenza-specific memory cells 
representing ~5 to 10% of effector CD8+ T cells found at the peak of expansion during 
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primary infection (276,277).These long-lived memory cells can rapidly respond to a 
secondary infection with influenza virus.  
Although the exact definitions are still controversial, memory T cells established after 
infection can be divided into two subsets: TCM which preferentially localize to the lymphoid 
tissues, and TEM found mainly in peripheral sites of infection (343,431). Numbers of TCM in 
lymphoid sites appear to remain relatively constant, if not slightly increased, while the 
number of TEM at peripheral sites steadily decreases in the months after pathogen 
clearance. Although both lean and obese mice demonstrated the expected increase in % 
TCM and decrease in TEM, the TEM in the lungs of the obese animals declined at a significantly 
faster pace resulting in a 10% reduction in the numbers of TEM present versus the lean 
controls. This reduction in the numbers of influenza-specific TEM in the lungs of obese mice 
has significant health implications since the protective capacity from a secondary infection 
can be directly linked to the number of pathogen-specific memory T cells present in the 
tissue prior to secondary infection (367)  Therefore, as we have already observed a 
decrease in protective capacity in influenza-specific memory T cells in obese mice (443), 
reduction in numbers of these cells could decrease protection even further. 
Memory cells persist under normal conditions by undergoing intermittent cell division, 
called bystander proliferation, about once every two weeks (444). Originally, the 
maintenance and survival of memory T cells was thought to be mediated by signals arising 
from contact with depots of persistent antigens; however, memory cells have been shown to 
survive not only in the absence of antigen but also in the absence of MHC molecules 
(445,446). Survival of memory cells now appears to be maintained by members of the 
common gamma chain (γc) family of cytokines, IL-15 and IL-7. 
IL-15 is essential for the regulation of slow, intermittent basal homeostatic 
proliferation of antigen-specific CD8+ memory T cells (379). Viral challenge of IL15-/- and IL-
15Rα-/- mice show that IL-15 is dispensable for the generation of antigen-specific CD8+ 
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memory T cells; however, the memory T cell pool decreased over time (386,387), as 
bystander proliferation fails to occur. Wildtype memory CD8+ T cells transferred into IL-15-/- 
mice fail to proliferate and disappear rapidly (388). Overexpression of IL-15 increased the 
numbers of memory CD8+ cells (389,390). In the lean mice, IL-15 mRNA expression was 
maintained at a constant level; however, expression of mRNA for IL-15 in the obese 
animals. was approximately 30 times greater at d 84 pi compared d 33. This increase in IL-
15 mRNA did not result in increased TEM. In fact, fewer TEM were found in the obese lung. 
Reasons for this discrepancy may be due to reduced IL-15 receptor (IL-15R) or a blockade 
of IL-15 signaling.  
The IL-15R consists of high-affinity IL-15Rα, IL-2/15Rβ (CD122) and γc subchains 
that form a heterotrimeric receptor complex. Memory CD8+ T cells express high levels of 
CD122. Obese, but not lean, Zucker rats have significantly decreased expression of mRNA 
for the γc and CD122 subunits of the IL-15 receptor while IL-15Rα remained unchanged 
(406).  While the mRNA expression of CD122 and IL-15Rα in the lungs of lean and obese 
mice were not found to be different (data not shown), the numbers of TEM expressing CD122 
were significantly reduced in the lungs of diet-induced obese mice 33 days post primary 
infection. In addition, mean fluorescence intensity of CD122 was also significantly reduced 
on TEM expressing the receptor, indicating a decreased amount of expression on these cells. 
However, by day 84, there was no difference in CD122 expression between lean and obese 
mice. 
Leptin resistance can also play a role in decreased TEM cells in the lungs of obese 
mice.  Elevated levels of leptin in the obese state results in attenuated central leptin 
signaling, with the possibility of decreased signaling in the periphery (119). Leptin, IL-7 and 
IL-15 share structural homology and signal through the Janus Kinase (JAK)-Signal 
Transducer and Activator of Transcription (STAT) pathway. In the lungs of obese mice, 
95 
 
leptin receptor (ObR) mRNA expression was significantly decreased at d 33 pi and did not 
increase over time as was found in the lean controls, suggesting that leptin signaling was 
likely impaired.  
Characteristic of leptin resistance, mRNA expression of SOCS-1 and SOCS-3, 
potent inhibitors of JAK-STAT signaling, were significantly increased in the lungs of obese 
mice. The participation of SOCS proteins, particularly SOCS-3 but also SOCS-1, as 
negative-feedback regulators of leptin signaling has been suggested as a causal factor for 
central leptin resistance (119,124,447). Indeed, SOCS-3 deficiency elevates leptin 
sensitivity and confers resistance to diet-induced obesity (142,448). While SOCS3- has not 
yet been directly linked to IL-15 signaling, it has been observed that SOCS-1 expression can 
directly regulate IL-15 driven homeostatic proliferation and SOCS-1-/- mice accumulate 
CD44+/CD8+ memory phenotype T cells which express elevated levels of CD122 (449,450). 
We observed a decrease in the numbers of CD44+/CD8+ memory T cells in obese mice 
despite an increase in IL-15 mRNA expression. Therefore, the increased SOCS expression 
in the lungs due to leptin resistance could be responsible for the failure of IL-15 to signal and 
thereby preventing the bystander proliferation required for memory T cell maintenance and 
resulting in a significantly reduced, lung-resident TEM population over time. 
 Obesity has also been associated with chronic inflammation and, indeed, significant 
increases in IL-6 and tumor necrosis factor (TNF) α mRNA expression were seen in the 
lungs of obese mice at d 33 and d 84 pi. This increased inflammation has been associated 
with leptin resistance, as these cytokines could contribute or be resultant of upregulation of 
SOCS proteins (451). 
While maintenance of memory T cell populations is regulated by IL-15 and IL-7, 
other factors could contribute to the reduction in the numbers of influenza-specific TEM in the 
lungs of obese mice over time.  Both IL-15 and IL-7 increase the resistance of memory T 
cells to apoptosis, allowing them to persist for long periods of time. Interestingly, leptin 
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signaling can also result in reduction of T cell apoptosis as leptin treatment has been found 
to prevent the decline of T cell numbers in the fasted state (452). If memory T cells in the 
lungs of obese mice are leptin resistant, then memory cells in the obesigenic environment 
would be at increased sensitivity to inflammation-induced apoptosis. 
Diet-induced obese mice are able to generate influenza-specific memory CD8+ T 
cells; however, the functional capability of these cells (443) and their ability to be maintained 
in the lung is significantly reduced. The understanding of memory T cell maintenance is still 
in its infancy; however, it is clear that IL-15 and IL-7 and their subsequent signals are 
important for maintaining the memory cell population over time. Our study has shown, for 
the first time, that diet-induced obesity can affect the maintenance of influenza-specific 
memory T cell populations in the lungs. This decrease in memory T cell numbers may be 
due to peripheral leptin resistance in the obesigenic lung microenvironment affecting IL-15 
function. Overall, decreased numbers of TEM over time, coupled with the decreased 
functional capability of these cells, suggests that obesity presents an even greater risk to 
increased morbidity and mortality from infection with a heterologous pandemic strain. In 
addition, vaccine strategies that promote the generation of memory T cells may be less 
effective in an obese population. 
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Figure 3.1: Diet-induced obese mice weigh more than lean controls at all time points 
post infection. Mice were weighed at d 33 and d 84 pi. Data is expressed as mean weight 
(n=6 per group) +/- SEM, *p < 0.05, lean versus obese, § p< 0.05 , d 33 versus d 84. 
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Figure 3.2. Influenza-specific central memory T cells (TCM) increase over time in the 
lung and spleen. TCM (CD8
+/DbNP366-74
+/CD44+/CD62L+) were identified in the lung (A, B) 
and spleen (C, B) using flow cytometry. Data are expressed as percent and total number of 
cells (n= 6 per group) ± SEM. *p < 0.05, lean versus obese, § p< 0.05 , d 33 versus d 84. 
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Figure 3.3. DIO mice maintain significantly reduced numbers of influenza-specific 
CD8+ effector memory T cells (TEM) in the lungs. Effector memory T cells (CD8
+/DbNP366-
74
+/CD44+/CD62L-) were identified in the lung using flow cytometry. Percent (A, B) and total 
numbers (C) were calculated. Data are expressed as percent and total number of cells (n= 6 
per group) ± SEM. *p < 0.05, lean versus obese, § p< 0.05 , d 33 versus d 84. 
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Figure 3.4. CD122 expression on influenza-specific TEM cells is minimally 
downregulated in the lungs of obese mice. CD122 expression on effector memory T cells 
(CD8+/DbNP366-74
+/CD44+/CD62L-) was identified in the lung using flow cytometry. Percent 
(A, B) and mean fluorescence intensity (C) were analyzed. Data are expressed as percent 
and mean fluorescence intensity of CD122 expression (n= 6 per group) ± SEM. *p < 0.05, 
lean versus obese, § p< 0.05 , d 33 versus d 84. 
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Figure 3.5. Elevated and blunted mRNA levels for murine IL-15 and IL-7, respectively, 
were detected in the lungs of obese mice. qRT-PCR was performed and β-actin 
expression was determined for all samples and used to normalize the gene expression 
levels for each cytokine. mRNA levels of IL-15 (A) and IL-7 (B) were tested. Data are 
expressed by normalization to β-actin values (n = 5-6 per group) ± SEM. *p < 0.05, lean 
versus obese, § p< 0.05 , d 33 versus d 84. 
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Figure 3.6. mRNA levels for murine leptin receptor (ObR) are blunted while inhibitors 
of leptin signaling were elevated in the lungs of obese mice. qRT-PCR was performed 
and β-actin expression was determined for all samples and used to normalize the gene 
expression levels for each cytokine. mRNA levels of ObR (A) as well as SOCS1 (B) and 
SOCS3 (C) were tested. Data are expressed by normalization to β-actin values (n = 5-6 per 
group) ± SEM. *p < 0.05, lean versus obese, § p< 0.05 , d 33 versus d 84. 
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Figure 3.7. mRNA levels for murine TNFα and IL-6 were greatly increased in the lungs 
of obese mice. qRT-PCR was performed and G3PDH expression was determined for all 
samples and used to normalize the gene expression levels for each cytokine. mRNA levels 
of IL-6 (A) and TNFα (B) were tested. Data are expressed by normalization to β-actin values 
(n = 5-6 per group) ± SEM. *p < 0.05, lean versus obese. 
 
 
 
 
 
 
 
 
  
 
CHAPTER IV 
 
GENERATION OF INFLUENZA-SPECIFIC MEMORY T CELLS IN A DIET-INDUCED 
OBESE HOST DURING A PRIMARY INFLUENZA INFECTION 
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A. ABSTRACT 
 Antigen-specific memory T cells generated during a primary infection confer 
protection against heterologous viral strains. Previous studies in our laboratory have shown 
that function and maintenance of influenza-specific memory CD8+ T cells is significantly 
impaired in the lungs of obese mice. Since development of these memory T cells is 
dependent on the primary response to influenza infection, we observed the development of 
influenza-specific memory T cells in the lungs of lean and obese mice during a primary 
influenza infection. Following infection with influenza X-31, obese mice had increased 
morbidity and increased viral load in the lungs starting at d 1 p.i. In addition, antiviral 
cytokine expression was severely reduced. As a result of the increased viral load, obese 
mice displayed increased numbers of influenza-specific CD8+ T cells responding to infection 
in the lungs. These cells expressed significantly increased levels of the primary effector-
associated transcription factors T-bet and Blimp-1 while expression of the memory 
formation-associated Eomesodermin was significantly reduced. Therefore, obese mice had 
increased severity of infection due to inability to prevent early viral replication in the 
respiratory epithelium. The resultant viral load then prompted the CD8+ T cells response to 
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generate increased numbers of influenza-specific effector CD8+ T cells required for viral 
clearance and to drive the differentiation program away from memory T cell formation. 
 
B. INTRODUCTION 
Obesity has become a worldwide epidemic; however, it’s influence on the response 
to viral infection is still poorly understood. In the United States alone, 68.0% of the US 
population has a BMI ≥ 25 meaning that 2 out of every 3 people are overweight or obese (6). 
Obesity can be considered an over accumulation of white adipose tissue (WAT) due to 
increased caloric intake versus caloric expenditure (9,62). WAT is now considered an 
important part of body regulation and can act as an endocrine organ, secreting numerous 
factors which can affect several metabolic pathways. These “adipokines” participate in a 
wide variety of physiological or physiopathological processes including food intake, insulin 
sensitivity and inflammation. In addition, many of the adipokines have been found to play an 
intricate role in various aspects of the innate and adaptive immune response (63-66). 
Obesity has been linked to numerous health problems and chronic diseases (10,11) and 
obese individuals have been found to have a greater risk of infection in the hospital setting 
(168,171). With adipose acting as an endocrine organ, it is not surprising that local, obesity-
driven changes in adipokine secretion can have a systemic impact on several branches of 
the immune system (14,15,63,66). However, the effects of these changes on the response 
to a viral infection are poorly understood. 
One such viral infection which poses a significant threat to global public health is 
influenza. Influenza is a highly contagious, seasonal respiratory illness caused by the 
influenza virus. Influenza viruses undergo continual mutation (drift) in surface antigens and 
occasional gene reassortment (shift) resulting in heterologous strains with serologically 
distinct surface proteins. Therefore, a vaccine which promotes a robust memory B cell 
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antibody-based response to the surface proteins of one strain of influenza could be 
ineffective for a strain encountered the next season expressing different surface proteins 
(267). By comparison, memory T cells generated during primary influenza infection can 
target internal proteins common and less variable among influenza strains, making them 
more effective against encounters with heterologous virus stains (268).  
Development of functional, fully protective influenza-specific memory CD8+ T cells is 
highly dependent on the primary encounter with the influenza virus. While the exact 
mechanism which determines the development of memory T cells is still under debate, 
current theory suggests that both initial antigen contact and environmental effects play a role 
in memory cell generation. The balance of these signals is very important and there appears 
to be a fine tightrope walk between development of long-lived, protective memory T cells 
and enough effector cells to be able to clear the infection (275,295,296). Previous studies in 
our laboratory have shown that diet-induced obesity in mice reduces both the protective 
capacity of influenza-specific memory T cells and their ability to be maintained in the obese 
lung microenvironment (443) (See Chapter II and Chapter III). Since these factors are highly 
dependent on the primary response to influenza infection, we examined the development of 
influenza-specific memory T cells in diet-induced obese mice during a primary influenza 
infection. 
 
C. MATERIALS AND METHODS 
 
Animals.  
Weanling, male C57BL/6J mice were obtained from Jackson Laboratories (Bar Harbor, ME, 
USA). All mice were housed at the University of North Carolina Animal Facility, which is fully 
accredited by the American Association for Accreditation of Laboratory Animal Care. 
Animals were housed 4/cage under pathogen-free/viral Ab-free conditions and maintained 
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under protocols approved by the Institutional Animal Use and Care Committee. Mice were 
randomized to receive either a low-fat/no-sucrose diet or a high-fat/high-sucrose diet for 20 
wk. The diets, previously described by Surwit et al. (50,409), were obtained from Research 
Diets (New Brunswick, NJ, USA). Previous studies in our lab (199) and others (410,411) 
have confirmed that these diets result in significant diet-induced obesity (increased body 
weight, increased body fat mass) in these mice.  
 
Influenza viruses and infection.  
Influenza virus strain X-31 (H3N2) (a generous gift from David Woodland, Trudeau Institute, 
Saranac Lake, NY, USA) was grown in the allantoic fluid of embryonated hen’s eggs. 
Created by Edward Kilbourne (1969), influenza X-31 is a mouse-adapted recombinant 
influenza virus consisting of the external hemagglutinin (HA) and neuramidase (NA) proteins 
of A/Aichi/2/68 (H3N2) and the internal proteins of A/Puerto Rico/8/34 (H1N1) (412). The X-
31 strain is sublethal and efficient at producing memory T cells which are able to prevent a 
lethal infection with a secondary A/PR/8 infection (413). For infection, following 20 weeks on 
the diets, lean and obese mice were anesthetized i.p. with ketamine/xylazine and 
subsequently inoculated intranasally with 300 EID50 live X-31 virus in 0.03 mL sterile PBS. 
Mice were maintained on the diets over the course of the infection.  
 
Quantitation of lung and spleen mRNA cytokine levels:  
Lung and spleen samples were collected on d 33 and 84 p.i. and total RNA was isolated 
using the TRIzol method. Reverse transcription was carried out with Superscript II First 
Strand Synthesis kit (Invitrogen, Carlsbad, CA, USA) using oligo (dT) primers. Following 
previously described methods (199), mRNA levels for murine G3PDH, IL-6, TNFα, MCP-1, 
MIP-1α, Blimp-1, Eomes and ObR were determined using quantitative real time polymerase 
chain reaction (qRT-PCR).   
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Isolation of cells from the lungs, spleen and draining lymph node:  
As previously described (200), lungs from lean and obese mice were removed, digested in 
HBSS (with calcium and magnesium) supplemented with 160 U/mL Collagenase type 1 
(Worthington, Lakewood, NJ, USA). Samples were processed into single-cell suspensions 
by mechanical agitation of a Stomacher (Seward, West Sussex, UK) and strained through a 
40-µm nylon filter. Cells were subjected to red blood cell lysis using ACK lysis buffer for 5 
min at room temperature, washed, counted then subjected to analysis by flow cytometry.  
 
Flow Cytometry:  
At least 1 x 106 cells were stained with fluorescein isothiocyanate (FITC)-anti-CD44, Pacific 
Blue-anti-CD62L, phycoerythrin (PE)-anti-Eomes, Allophycocyanin (APC)-anti-IFNγ, Alexa 
Flour-647-anti-Tbet (eBioscience, San Diego, CA, USA), peridinin-chlorophyll-protein 
complex (PerCP)-anti-CD8α (BD Biosciences, San Jose, CA, USA), and APC-Cy7-anti-CD3 
(BioLegend, San Diego, CA, USA). CD8+ T cells specific for the major epitope of the PR8 
nucleoprotein were identified using a PE-labeled DbNP366-374. Non-specific tetramer staining 
was analyzed using an irrelevant tetramer towards herpes simplex virus. Samples were 
analyzed on a Cyan ADP flow cytometer (Beckman Coulter, Fullerton, CA, USA) and data 
was analyzed using FlowJo software (TreeStar, San Jose, CA, USA).  
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D. RESULTS 
 
Diet-induced obese mice have increased percentage of body weight lost post 
influenza infection compared to lean mice (Figure 1). As expected, mice placed on a high 
fat diet gained significant amounts of weight compared to lean controls (Fig. 1A). Following 
infection with influenza X-31, consistent with illness, both groups lost weight; however, the 
infection was more severe in the obese mice as indicated by increased percent body weight 
lost early in infection and delayed weight regain (Fig. 1B). 
 
Obese mice have significantly increased viral load in the lungs post influenza 
infection (Figure 2). Following X-31 infection, cells of the respiratory epithelium are infected 
with virus which then replicates and spreads to other lung cells (221). In the lean mice, virus 
first appeared at d 3 p.i., peaked at d 7 and was undetectable at d14. In contrast, significant 
levels of viral mRNA were detected in the lungs of obese mice at d 1 p.i. and were still 
detectable by d 14. By d 21, obese mice had cleared the virus.  
 
Antiviral cytokine mRNA expression is altered in the lungs of obese mice (Figure 3). 
Respiratory epithelial cells are a primary target of influenza virus and play an important role 
in the pathogenesis of influenza infection. Infection of respiratory epithelial cells induces the 
production of the antiviral cytokines, IFN-α and IFN-β (418-422). Lean mice had an increase 
in IFNα mRNA expression by d 3 post X-31 infection; however, obese mice did not increase 
IFNα mRNA expression until d 7 p.i. (Fig. 3A). For IFNβ, both lean and obese mice 
increased mRNA expression at d 3 and d 7 p.i. (Fig. 3B).  
 
Obese mice have significantly increased number of influenza-specific CD8+ T cells in 
their lungs post influenza infection (Figure 4). Resolution of a viral infection relies on the 
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induction of pathogen-specific CD8+ T cells (241). Following X-31 infection, both lean and 
obese mice had a large infiltrate of inflammatory cells into the lung (Fig 4A), most of which 
was lymphocytes (Fig. 4B). Interestingly, obese mice had approximately 2x the cellularity 
versus lean controls at d 7 (Fig. 4A, B). Percentage of activated, influenza-specific CD8+ T 
cells significantly increased in the lungs of lean and obese mice starting at d 10 p.i. with a 
decreased percentage in the lungs of obese mice at d 10 (Fig. 4C). Of note, the number of 
influenza-specific T cells in the lungs of obese mice peaked at d 7 post infection; however, 
peak numbers were observed at d 10 in the lungs of lean mice (Fig, 4D). 
 
Increased IFN-γ expressing cells in the lungs of obese mice post X-31 infection (Figure 
5). CD8+ T cells act to inhibit viral replication by destroying virally infected cells through the 
secretion of IFN-γ and perforin/granzyme B as well as Fas/FasL pathway (246). Although 
IFN-γ is not directly involved in the lysis of infected cells, IFN-γ secretion enhances the 
development of cell-mediated immunity, activates macrophages, and increases antigen 
presentation (250,251). IFN-γ mRNA expression was significantly increased in the lungs of 
lean and obese mice at d 7 and d 14 post infection (Fig. 5A). At d 7 p.i., obese mice had a 
significant increase in the number of influenza-specific CD8+ T cells producing IFN-γ 
compared with lean mice. 
 
Increased proinflammatory mRNA expression in the lungs of obese mice (Figure 6). 
Obesity has been associated with a chronic, low-grade inflammatory state resulting from 
altered secretion of adipokines and cytokines from adipose tissue (14,91). Before X-31 
infection, mRNA levels of IL-6, TNF-α, MCP-1 and MIP-1α were 2 to 5 fold higher in the 
lungs of obese versus lean mice (Fig 6A). Following infection, approximately 3x greater IL-6 
mRNA expression was observed in the lungs of obese mice at d3 p.i. (Fig. 6B). No 
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differences in mRNA expression of TNFα, IL-12, MCP-1 or MIP-1α between lean and obese 
mice were seen following influenza challenge (data not shown).  
 
Obese mice have altered expression of memory T cell precursor transcription factors 
in the lungs post X-31 infection (Figure 7). Following influenza infection, antigen contact, 
inflammation and costimulation can stimulate the inherent and environmental programming 
of effector CD8+ T cells which may control the expression of key transcription factors 
important for memory T cell generation such as T-bet, Eomesodermin (Eomes) and Blimp-1 
(275,285,296,331). Following influenza challenge, obese mice had approximately double the 
number of CD8+ effector cells expressing T-bet at d 7 post infection (Figure 7A). In addition, 
Blimp-1 mRNA expression was almost double in the lungs at d 14 p.i. (Figure 7B) Perhaps 
most strikingly, mRNA expression of eomesodermin mRNA was significantly decreased at d 
7 pi in the lungs of obese mice versus lean controls (Figure 7C). In concordance the 
percentage of CD8+ cells expressing Eomes was significantly decreased at d 3 and d 7 post 
infection as measured by flow cytometry (Figure 7D). 
 
Obese mice have decreased leptin receptor (ObR) mRNA expression in the lung 
(Figure 9). Leptin signaling has been associated with the ability to alter the immune 
response and obesity has been associated with a state of leptin resistance. ObR mRNA was 
found to be significantly decreased in the lungs of obese mice prior to influenza infection 
and expression did not increase at d 1 pi as seen in the lean mice. Additionally, ObR mRNA 
expression remained low in the lungs of obese mice following influenza challenge and was 
significantly decreased at d 7 pi compared to lean controls.  
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E. DISCUSSION 
 
 Recent studies of the generation of long-term immunity and efficacious vaccination 
against viral agents have begun to focus on the generation of long-lived, antigen-specific 
CD8+ memory T cells. From these studies, it has become apparent that the generation of 
functional CD8+ memory T cells requires a “balancing act” between memory cell potential 
and terminal differentiation into full effector T cells (275,282,285,296). Antigen density on 
the dendritic cell and time of contact with the APC, costimulatory factors and signals and 
levels of inflammatory cytokines could all play a role in programming the development of 
memory potential (283). Any alteration of these factors may result in altered generation of a 
protective pool of influenza-specific memory T cells. 
Resolution of a viral infection often relies on the induction of a CD8+ T cell response 
(241). CD8+ T cells actively identify and eliminate virally infected cells. During an influenza 
virus infection, T cell responses peak between days 7-10 p.i., resulting in viral clearance by 
day 15 (242-245). Indeed, in our model we observe peak numbers of influenza-specific T 
cells at d 7 post X-31 infection. However, obese mice had almost double the number of 
influenza-specific cells in the lungs compared to lean controls. In accordance, viral load was 
greatly increased in the obese mice which may have stimulated the observed increase in 
number of influenza-specific CD8+ T cells in order to handle the increased viral load. 
CD8+ T cells are required for resolution of a viral infection and to clear virally infected 
cells. These functions are achieved through the secretion of IFN-γ and perforin/granzyme B 
as well as Fas/FasL pathway (246). While IFN-γ mRNA expression in the lungs of lean and 
obese mice did not differ between groups, the number of influenza-specific CD8+ T cells 
producing IFN-γ was significantly increased in the lungs of obese mice versus lean controls, 
again, likely in response to the increased viral load. 
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Following viral infection, respiratory epithelial cells produce antiviral and 
inflammatory cytokines in order to limit viral infectivity and to activate and attract the immune 
cells to the site of infection. IFNα and IFNβ  are major antiviral cytokines and can mediate 
direct antiviral activity of cells. In addition, these cytokines also have antiproliferative and 
immunomodulatory function (229). Obese mice displayed a trend towards decreased and 
delayed expression of these antiviral signals which may have resulted in the significantly 
increased viral load seen in the lungs of obese mice.  
Recent evidence points out that inflammatory signals received during the primary 
infection can also determine the size and function of the memory cell pool. Inflammation can 
act as a “third signal” in the determination of the balance of effector and memory 
differentiation. Increased inflammation is associated with increased primary effectors but 
decreased memory precursors and differentiation into long-term memory. Reduced 
inflammation leads to reduced effector CD8+ T cells and T cell contraction as well as greater 
numbers of CD8+ memory T cells (281). mRNA expression of proinflammatory cytokines IL-
6, MCP-1 and MIP-1α was greatly increased in the lungs of obese mice before X-31 
infection and IL-6 mRNA expression was increased at d3 post X-31 infection compared to 
lean mice. This increased inflammation may have contributed to the increased number of 
activated CD8+ T cells responding to the infection in the lungs of obese mice. 
Several transcription factors have been shown to coordinate and regulate the 
balance between memory T cell and short lived effector T cell formation (282,327,332). The 
transcription factor T-bet is the master regulator of type I effector differentiation (290,328) 
and inflammation-induced T-bet can control effector and memory fate decisions in CD8+ 
T cells. Increased T-bet leads to differentiation towards primary effector CD8+ T cells and 
away from memory precursors. Inflammation has been shown to induce T-bet expression 
and promote effector T cell generation (290,295). Indeed, in the obese mice, the number of 
effector cells expressing T-bet was significantly increased in the lungs of obese mice at d 7 
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post infection suggesting a drive towards primary effector CD8+ T cell generation and away 
from memory T cell formation. Another transcription factor, Blimp-1, is also thought to be 
involved enhancing the formation of short-lived effector cells versus memory precursors. 
Indeed, Blimp-1 deficiency promotes the formation of memory precursors (MPEC) 
(330,331). In the obese mice, Blimp-1 mRNA expression was significantly increased at d 14 
post infection. Increased expression of both T-bet and Blimp-1 indicates a greater 
propensity for CD8+ T cells to be short-lived effector T cells at the expense of generating 
MPEC to later form a pool of memory T cells. A third transcription factor, Eomesodermin 
(Eomes) is proposed to promote memory formation (327). Eomes mRNA expression was 
found to be reduced in the lungs of obese mice following influenza infection with reduced 
numbers of CD8+ T cells being positive for Eomes. Thus, the increase in T-bet and Blimp-1 
and decreased Eomes expression all point towards an increase in primary, short-lived 
effector T cell formation and a decrease in the number of cells forming the influenza-specific 
memory T cell pool. These data indicate that there may be a decrease in memory precursor 
formation in the obese mice versus the lean controls.  
 One factor that may tie together all of these changes is the leptin resistance 
associated with the obesigenic state. Leptin levels act as a general signal of energy 
reserves and to modulate food intake and, therefore, leptin concentrations increase 
proportionately to adipose mass (which results in high circulating levels in obese individuals 
(104-108). Obesity has been associated with a state of central leptin resistance, and, 
possibly, a state of peripheral leptin resistance due to an overaccumulation of suppressor of 
cytokine signaling (SOCS) proteins (136,137). Expression of the type I interferons, IFNα and 
IFNβ, can also be repressed by SOCS proteins. Therefore, leptin resistance in the 
respiratory epithelium may account for the reduced antiviral response seen in the obese 
lung and the subsequent increase in viral load (132,453,454). Leptin receptor (ObR) mRNA 
expression was found to be significantly decreased in the lungs of obese mice prior to 
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influenza challenge and did not increase following influenza infection as was seen in the 
lungs of the lean mice. This reduction of ObR could indicate a state of leptin resistance in 
the lungs of the obese mice.  Indeed, elevated leptin levels have also been observed in the 
serum of our obese mice during previous studies (443). 
 Taken together, this study indicates that memory T cell generation during a primary 
response to influenza infection is impaired in obese mice. The increased inflammation and 
decreased and unresponsive leptin receptor expression in the lungs of obese mice may 
contribute to an inability of lung epithelial cells to respond to viral infection and may prevent 
the expression of antiviral IFNα and IFNβ. This decrease in antiviral IFN expression then 
resulted in an increased replication of virus in the epithelium resulting in increased viral 
loads in the obese mice at d 1 and delayed clearance of the virus at d 14 p.i. Subsequently, 
increased viral loads and inflammation during infection result in increased number of 
influenza-specific effector T cells needed to clear the infection. This increase could be 
tipping the balance between effector and memory T cell generation with increased primary 
effector T cells that will eventually go through activation-induced cell death and reduced 
numbers of MPEC. These conclusions are supported by the transcription factor data 
indicating increased T-bet and Blimp-1 expression (indicators of primary effectors) and 
reduced Eomes expression (indicators of MPEC) in responding CD8+ T cells in the lungs of 
obese mice. These data help to understand why we have observed reduced functionality 
and decreased maintenance of influenza-specific memory T cells in diet-induced obese 
mice. In order to fully understand how generation of memory T cells is affected by the 
obesigenic environment, these studies must be repeated with a larger number of samples 
and more time points. In addition, ex vivo studies on activation and function of CD8+ T cells 
are necessary to understand how their intrinsic programming and environmental experience 
affect their ability to develop into bona fide memory T cell precursors. 
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Figure 4.1. Morbidity in lean and obese mice during primary response to influenza 
infection. Mice placed on a high fat diet gained significant amounts of weight compared to 
lean controls (Fig. 1A). Following infection with influenza X-31, both groups lost weight; 
however, the infection was more severe in the obese mice as indicated by increased 
percent body weight lost early in infection and delayed weight regain (Fig. 1B). Data 
expressed as g of weight of percentage of body weight lost (n=12-24/group) ± SEM. 
*p<0.05, lean versus obese. 
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Figure 4.2. Increased viral load in the lungs of obese mice. Obese mice had greater viral 
mRNA expression in the lungs at d 1, 3 and 14 post infection. No virus was detected before 
X-31 infection (d 0). Data are expressed as change in M1 mRNA threshold cycle over 
uninfected controls (n=3-4/group) ± SEM. *p<0.05, lean versus obese. 
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Figure 4.3. Antiviral cytokine mRNA expression in the lungs following X-31 infection. 
mRNA expression of (Fig. 1A) IFNα and (Fig. 1B) IFNβ were measured in the lungs of lean 
and obese mice following primary X-31 infection. Data are expressed by normalization to 
G3PDH values (n = 3-4 per group) ± SEM. There were no significant differences in G3PDH 
values.  
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Figure 4.4. Number of responding influenza-specific CD8+ T cells in increased in the 
lungs of obese mice. Number of total cells (Fig. 4A), number of lymphocytes (Fig. AB) and 
percentage (Fig. 4C) and number (Fig. 4D) of influenza-specific effector T cells 
(CD8+/CD44+/DbNP366-74
+) following X-31 infection were measured by flow cytometry. Data 
are expressed as number or percent cells of total cells isolated (n = 3-4 per group) +/- SEM. 
*p<0.05, lean vs obese. a – p<0.05 versus d0 
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Figure 4.5. Obese mice have increased influenza-specific T cells producing IFN-γ 
following infection. mRNA expression of IFN-γ (Fig. 5A) was measured in the lungs of lean 
and obese mice following X-31 infection using quantitative real time-PCR. Data are 
expressed by normalization to G3PDH values (n = 3-4 per group) ± SEM. There were no 
significant differences in G3PDH values. *p<0.05, lean versus obese. (Fig. 5B) Number of 
influenza-specific T cells (CD8+/DbNP366-374
+/CD44+) producing IFN-γ following X-31 
infection. Data are expressed as number of total cells isolated (n = 3-4 per group) +/- SEM. 
*p<0.05, lean vs obese. a-p<0.05 versus d0 
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Figure  4.6. Inflammation-associated cytokine mRNA expression in the lung prior to 
and following primary infection.  (Fig. 6A) mRNA expression of IL-6, TNFα, MCP-1 and 
MIP-1α were measured in the lungs of lean and obese mice before X-31 infection. (Fig. 6B) 
mRNA expression of IL-6 was measured in the lungs of lean and obese mice following X-31 
challenge. Data are expressed by normalization to G3PDH values (n = 3-4 per group) ± 
SEM. *p<0.05, lean versus obese. 
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Figure 4.7. Differential expression of transcription factors associated with effector or 
memory formation in lean and obese mice. (Fig 7A) Number of CD3+CD8+ T cells in the 
lungs expressing T-bet was measured in lean and obese mice by flow cytometry. (Fig 7B) 
mRNA expression of Blimp-1 in the lung of obese mice. (Fig 7C) mRNA expression and (Fig 
7D) percentage of CD3+CD8+ cells expressing Eomes in the lungs of lean and obese mice. 
Cellular data are expressed as number or percentage of total cells isolated (n = 3-4 per 
group) +/- SEM. mRNA data are expressed by normalization to G3PDH values (n = 3-4 per 
group) ± SEM. *p<0.05, lean versus obese 
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Figure 4.8. Expression of ObR mRNA in the lungs of lean and obese mice following 
primary influenza X-31 infection.  mRNA expression of ObR was measured in the lungs of 
lean and obese mice following primary infection. Data are expressed by normalization to 
G3PDH values (n = 3-4 per group) ± SEM. There were no significant differences in G3PDH 
values. *p<0.05, lean versus obese 
 
 
 
 
 
 
 
 
 
  
 
CHAPTER V 
SYNTHESIS 
 
A. Overview of Research Findings 
 
Obesity has become a worldwide epidemic. Aside from numerous described 
comorbidities, obesity also appears to have a significant impact on the immune response. 
However, the effect of obesity on response to infection is just beginning to be understood. 
Infection with influenza virus remains a significant yearly cause of morbidity and mortality 
worldwide. Previous studies in our laboratory have demonstrated that diet-induced obesity in 
mice results in significant increases in morbidity and mortality versus lean controls 
(199,200).  
Development of influenza-specific memory CD8+ T cells is dependent on a balanced 
and effective primary response. Since we have demonstrated a significant dysregulation of 
the primary response to influenza infection in diet-induced obese mice, we hypothesized 
that obesity would also result in an impaired memory response to secondary influenza 
infection with a heterologous viral strain. Indeed, in this work, we have demonstrated that 
influenza-specific memory T cells in obese mice have a significantly reduced ability to 
respond to secondary challenge. In addition, we have shown that these cells are not 
maintained in the obesigenic environment.  
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B. Diet-induced obesity impairs the T cell memory response to influenza virus 
infection 
 Previous studies in our laboratory have shown that diet-induced obesity in mice 
significantly impairs the primary response to influenza infection resulting in increased 
morbidity and mortality (199,200). Since development of memory T cells depends on the 
primary response, we hypothesized that DIO mice would also impair a memory T cell 
response to a secondary influenza challenge. To test this hypothesis, lean and obese mice 
were first challenged with a nonlethal dose of influenza X-31. Following resolution of the 
primary infection and ensuring viral clearance, mice were then challenged with a lethal dose 
of influenza PR8. The memory response was then analyzed using a variety of methodology 
including qRT-PCR and flow cytometry. 
In our study, priming with influenza X-31 resulted in protection against the lethal dose 
of a heterologous PR8 strain of influenza with 100% survival in lean mice; however, obesity 
reduced this protective capacity resulting in ~25% mortality. Consistent with infection, both 
lean and obese mice lost weight following PR8 challenge, although the infection was more 
severe in the obese mice as indicated by the lack of weight regain after day 7 post infection. 
This increased severity of infection was confirmed by the increased lung pathology and viral 
titers in obese mice.  Early innate antiviral cytokines IFNα and IFNβ were significantly 
reduced in the lungs of obese mice which may have contributed to the higher viral titers and 
increased infiltrate found in lungs of obese mice. Additionally, infection associated 
upregulation of inflammatory cytokine expression was also found to be significantly blunted 
in the obese mice. 
Following a secondary challenge with influenza virus, memory CD8+ T cells in the 
lung airways respond to initial viral loads by generating signals, such as IFN-γ, to induce the 
antiviral response (364,365). The protective value of CD8+ T cell memory cells is strongly 
correlated to the ability to exert effector function at the site of infection (366). DIO mice had 
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significantly decreased overall IFN-γ mRNA expression in the lung. More specifically, obese 
mice were found to have decreased percentage and overall number of influenza-specific 
effector memory T cells producing IFN-γ post secondary challenge. Next, we tested whether 
production of IFN-γ by memory T cells during secondary infection in DIO mice may be due to 
impaired DC functionality. Interestingly, we found that in contrast to a primary influenza 
infection, DC from DIO mice were able to efficiently present antigen to lean and obese 
memory T cells; however, memory T cells from DIO mice had a significantly decreased 
ability to respond to presented antigen. 
Although the mechanistic link between obesity and diminished immune memory is 
not clear, a main factor which ties together obesity, inflammation and immune cell function is 
leptin resistance associated with the obese state. Leptin is recognized as an important 
mediator of immune function (434) and leptin expression is increased proportionately with 
adipose tissue mass, resulting in increased circulating levels in obesity (435). This chronic 
elevation appears to cause a state of leptin resistance in obese mice where leptin signaling 
is attenuated despite increased circulating levels (436).  Serum leptin was significantly 
increased in obese mice before secondary challenge and did not show an infection 
associated response as seen in the lean controls. Therefore, leptin resistance in obese mice 
may contribute to the reduced protective capacity of the memory response to secondary 
influenza infection 
To our knowledge, this is the first time that diet-induced obesity has been shown to 
affect the memory T cell response to a viral infection. It is apparent that diet-induced obesity 
results in an ineffective memory T cell response to influenza infection resulting in increased 
morbidity and mortality. Impairment of leptin signaling may contribute to this reduced 
functionality.  
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C. Influence of diet-induced obesity on maintenance of influenza-specific CD8+ 
memory T cells 
 
In the previous study, we found that diet-induced obesity in mice led to decreased 
protection from an infection with a heterologous strain of influenza virus. This decrease was 
found to be a result of impaired functionality of influenza-specific memory T cells in the lungs 
of obese mice (443). This reduced protection was associated with the memory T cell 
response since the number and function of influenza-specific CD8+ T cells responding to 
secondary infection was significantly reduced in obese mice. Following viral clearance, 
contraction of activated CD8+ T cells results in influenza-specific memory cells representing 
~5 to 10% of effector CD8+ T cells found at the peak of expansion during primary infection 
(276,277). These long-lived memory cells can rapidly respond to a secondary infection with 
influenza virus. Survival of memory cells now appears to be maintained by members of the 
common γc family of cytokines, IL-15 and IL-7. As the expression of both IL-7 and IL-15 can 
be affected by inflammatory cytokines and both share signaling pathways with the leptin 
receptor, we hypothesized that the maintenance of influenza-specific CD8+ memory T cells 
would be impaired in diet-induced obese mice compared to lean controls. 
 To test this hypothesis, lean and obese mice were infected with influenza X-31 and 
memory cell populations were assessed at days 33 and 84 post infection. Memory T cells 
established after primary infection can be divided into two subsets: central memory T cells 
(TCM) which preferentially localize to the lymphoid tissues, and effector memory T cells (TEM) 
found mainly in peripheral sites of infection (343,431). Numbers of TCM in lymphoid sites 
appear to remain relatively constant, if not slightly increased, while the number of TEM at 
peripheral sites steadily decreases in the months after pathogen clearance. Although both 
lean and obese mice demonstrated the expected increase in % TCM and decrease in TEM, 
the TEM in the lungs of the obese animals declined at a significantly faster pace resulting in a 
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10% reduction in the numbers of TEM present versus the lean controls at day 84 post X-31 
challenge. 
IL-15 is essential for the regulation of slow, intermittent basal homeostatic 
proliferation of antigen-specific CD8+ memory T cells (379). In the lean mice, IL-15 mRNA 
expression was maintained at a constant level. However, expression of mRNA for IL-15 in 
the obese animals was approximately 30 times greater at d 84 pi compared to d 33.  This 
increase in IL-15 mRNA did not result in an increase in TEM. In fact, fewer TEM were found in 
the obese lung. Reasons for this discrepancy may be due to reduced IL-15 receptor or a 
blockade of IL-15 signaling. While the mRNA expression of IL-15 receptor components 
CD122 and IL-15Rα in the lungs of lean and obese mice were not found to be different (data 
not shown), the numbers of TEM expressing CD122 were significantly reduced in the lungs of 
diet-induced obese mice 33 days post primary infection. In addition, mean fluorescence 
intensity of CD122 was also significantly reduced on TEM expressing the receptor, indicating 
a decreased amount of expression on these cells. 
Similar to our findings in the previous experiment, leptin signaling and leptin 
resistance in the obesigenic state may contribute to the decreased maintenance of memory 
T cells. Leptin, IL-7 and IL-15 share structural homology and signal through the JAK-STAT 
pathway. In the lungs of obese mice, leptin receptor (ObR) mRNA expression was 
significantly decreased at d 33 pi and did not increase over time as was found in the lean 
controls, suggesting that leptin signaling was likely impaired. Consistent with leptin 
resistance, mRNA expression of SOCS-1 and SOCS-3, potent inhibitors of JAK-STAT 
signaling, were significantly increased in the lungs of obese mice which may have impaired 
IL-15 signaling. 
The exact mechanism for the reduction of CD122 expression is not yet clear; 
however, several possible changes associated with diet-induced obesity could be the causal 
factor. Type I interferon signals (IFNα/β) appears to be very important for the production of 
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the basal level of IL-15. IFNα/β receptor-deficient mice have half as many CD122hi memory 
cells versus normal wildtype controls. This is even more pronounced in STAT1-deficient 
mice which are unresponsive to both IFNα/β and IFN-γ (446). Previous studies in our lab 
have shown that IFNα/β production is significantly reduced in obese mice (199,443). 
Therefore, a defect in the JAK-STAT signaling in T cells may be a causal factor in the 
decreased memory cell maintenance in the lungs of obese mice.  
One factor that could cause this decreased signaling would be peripheral leptin 
resistance associated with obesity. Leptin expression is increased proportionately with 
adipose tissue mass, resulting in increased circulating levels in obesity (435). This chronic 
elevation appears to cause a state of central leptin resistance in obese mice where leptin 
signaling is attenuated in the brain despite increased circulating levels (436,455); however, 
peripheral leptin resistance in cells of the immune system has also been suggested (75). 
Leptin, IL-7 and IL-15 share structural homology and signal through the JAK-STAT pathway. 
Indeed, in lean Zucker rats, lean mice and obese leptin-deficient (ob/ob) mice, IL-15 
administration inhibited fat deposition; however, recombinant IL-15 was unable to prevent fat 
deposition in leptin receptor-deficient obese (fa/fa) Zucker rats (406). The inability of IL-15 
administration to reduce fat deposition in leptin receptor-deficient rodents indicates that 
leptin receptor signaling can be very important for the function of IL-15. Previous studies in 
our lab have shown that obese mice have significantly increased serum expression of leptin 
and in contrast to lean mice, leptin expression was not augmented by acute infection (443). 
In the current study, leptin receptor mRNA expression was significantly decreased in the 
lungs of the obese mice at d 33 pi and did not increase over time as was found in the lean 
controls. The reduced expression of ObR could indicate a reduction of IL-15 signaling and, 
therefore, reduced IL-15 maintenance of memory T cells. The increased expression of ObR 
mRNA in lean mice was likely due to the weight gain over time.  
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From these data and that of the previous experiment, it is apparent that diet-induced 
obese mice are able to generate influenza-specific memory CD8+ T cells; however, the 
functional capability of these cells (443) and their ability to be maintained in the lung is 
significantly reduced. The understanding of memory T cell maintenance is still in its infancy; 
however, it is clear that IL-15 and IL-7 and their subsequent signals are important for 
maintaining the memory cell population over time. This study has shown, for the first time, 
that diet-induced obesity can affect the maintenance of influenza-specific memory T cell 
populations in the lungs and that this decrease in memory T cell numbers may be due to 
peripheral leptin resistance in the obesigenic lung microenvironment.  
 
D. Generation of influenza-specific memory T cells in a diet-induced obese host 
during a primary influenza infection 
Development of functional, fully protective influenza-specific memory CD8+ T cells is 
highly dependent on the primary encounter with the influenza virus. Current theory suggests 
that both initial antigen contact/interaction with an APC and environmental effects play a role 
in memory cell generation. The overall equilibrium of these signals is very important and it is 
important to be able to balance between development of long-lived, protective memory T 
cells and enough effector cells to be able to clear the infection (275,295,296). Alteration of 
any part of the immune program could result in an ineffective or diminished population of 
antigen-specific memory T cells. In our previous studies, we have shown both reduced 
functionality and reduced maintenance of influenza-specific memory CD8+ T cells in the 
lungs of diet-induced obese mice. Therefore, in this study, we sought to observe the 
development of these cells during a primary infection in diet-induced obese mice versus 
lean controls.  
Following influenza X-31 infection, diet-induced obese mice lost a greater 
percentage of body weight and weight regain was significantly delayed indicating increased 
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severity of illness. Obese mice had almost double the number of influenza-specific cells in 
the lungs compared to lean controls at d 7 post infection. Resolution of a viral infection often 
relies on the induction of a CD8+ T cell response and induction of induction of effector T cells 
can be proportional to the level of infection (241).  In accordance to increased cellularity, 
viral load was greatly increased in the obese mice starting at d 1 p.i. which may have 
stimulated the observed increase in number of influenza-specific CD8+ T cells in order to 
handle the increased viral load. In addition, the number of influenza-specific CD8+ T cells 
producing IFN-γ was significantly increased in the lungs of obese mice versus lean controls, 
again, likely in response to the need to clear a larger amount of virus. 
Following viral infection, respiratory epithelial cells produce antiviral and 
inflammatory cytokines in order to limit viral infectivity and to activate and attract the immune 
cells to the site of infection. IFNα and IFNβ  are major antiviral cytokines and can mediate 
direct antiviral activity of cells (229). Obese mice displayed a trend towards decreased and 
delayed expression of IFNα/β mRNA which may have resulted in the significantly increased 
viral load seen in the lungs of obese mice. Inflammatory signals were also altered in the 
lungs of obese mice which may have contributed to increased number of primary influenza-
specific effector CD8+ T cells seen in the obese lungs. mRNA expression of proinflammatory 
cytokines IL-6, MCP-1 and MIP-1α was greatly increased in the lungs of obese mice before 
X-31 infection and IL-6 mRNA expression was increased at d3 post X-31 infection compared 
to lean mice.  
Increased inflammation is associated with increased primary effectors but decreased 
memory precursors and differentiation into long-term memory (281). Indeed, increased 
number of activated CD8+ T cells responding to the infection could indicate a larger need for 
primary effectors and decreased memory T cell precursor formation. Several transcription 
factors have been shown to coordinate and regulate the balance between memory T cell 
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and primary effector formation (282,327,332). Expression of these factors in the obese lung 
indicated an increase in short-lived effector CD8+ T cell formation and a possible decrease 
in memory T cell precursors. Expression of effector-promoting factors T-bet and Blimp-1 was 
significantly increased in the lungs of obese mice at d 7 and d 14 p.i. respectively. 
Expression of the memory precursor-associated factor, Eomes, was found to be significantly 
decreased. Thus, the increase in T-bet and Blimp-1 and decreased Eomes expression all 
point towards an increase in primary, short-lived effector T cell formation and a decrease in 
the number of cells forming the influenza-specific memory T cell pool.  
 The inability of lung epithelial cells in obese mice to respond to viral infection and 
express antiviral IFN, possibly due to leptin resistance, could result in the increased viral 
load and subsequent increase in number of influenza-specific effector T cells needed to 
clear the infection. This increase could be tipping the balance between effector and memory 
T cell generation with increased primary effector T cells and reduced numbers of MPEC. 
Taken together, this study indicates that memory T cell generation during a primary 
response to influenza infection is indeed impaired in obese mice. These findings correlate 
with our previous observation of decreased influenza-specific memory CD8+ T cell function 
and maintenance in the lungs of obese mice. 
 
E. Future Studies 
 
E.1. The impact of the obesigenic lung microenvironment 
The lung airways are distinct from other non-lymphoid tissue since: (i) they contain 
surfactant proteins that are known to block T cell proliferation and (ii) they are directly 
exposed to the outside environment (456). The environment in which cells reside and the 
ability to migrate to potential sites of infection are very important for function and 
protectiveness of memory cells. The microanatomy of the secondary lymphoid organs as 
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well as tissue-specific events are critical for the immune response to specific infectious 
agents (457). Obese subjects display greater incidence of asthma and pulmonary related 
complications (21,172,458). Additionally, increased inflammatory cytokines and chemokines 
during influenza challenge can result in increased cellular recruitment to the lungs causing 
airway occlusion and bystander damage to the lung tissue itself. These changes may cause 
alterations in both innate and adaptive systems which can have both helpful and detrimental 
effects (459). Therefore, the obese lung environment may negatively affect CD8+ memory T 
cells.  
Migration of TCM from lymphoid to nonlymphoid tissue results in the conversion to a 
TEM phenotype (361). Additionally, the lung airway environment itself has been shown to 
directly influence surface markers and maintenance on CD8+ memory cells in the absence 
of antigenic exposure. Memory cells isolated from the spleen and transferred intratracheally 
(i.t.) into the lungs downregulate LFA-1, CD27, CD127 and Ly6C and increase CD69 while 
the same cells given intraperitoneally (i.p.) do not go through this change (353,362). Gene 
expression profiles of CD8+ memory cells in lung airway and spleen generated during 
influenza infection reveal a “focusing” of genes to favor effector function in the airway 
environment (363).  
It has been well established that the adoptive transfer (AT) of influenza-specific 
cytotoxic T lymphocytes into a naïve host is protective against influenza infection (460). 
Direct evidence for the protective capacity of AT lymphocytes has been proven using i.t., 
intravenous (i.v.) and i.p. transfer studies (352,353,362). A single adoptive transfer of cells 
from one experimental group to another allows for the determination of environmental 
effects on the transferred cells. Adoptive transfer studies utilizing DIO in congenic mouse 
models would greatly further our understanding of the effect of memory T cell function and 
maintenance in the obesigenic lung microenvironment. 
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E.2. The effect of DIO on antigen-specific memory T cell migration 
It is very important for antigen-specific memory T cells to be able to localize to the 
most likely site of reinfection. Memory T cells are widely distributed throughout the body; 
however, the site of infection and type of tissue infected can greatly influence memory T cell 
distribution (461). Since TEM cannot proliferate in the airways, the current paradigm is that 
memory CD8+ populations in the lung are maintained by continual recruitment from the TCM 
population (353). The exact mechanism for memory T cell recruitment and establishment in 
the lung airways is unknown. Kohlmeier et al. (2007) hypothesized that continuous exposure 
to inhaled antigens and microorganisms could produce a state of low level inflammation 
which could stimulate chemokine production and memory cell recruitment (362). Infection of 
the lungs by influenza virus results in markedly increased numbers of influenza-specific 
memory T cells to be maintained in the lungs for long periods post infection. These cells 
preferentially migrate to the site of original infection versus other peripheral sites which did 
not contain replicating virus. This “preference” of antigen-specific memory T cells to migrate 
to the site of primary infection allows them to be present at the site of most likely reinfection 
(461).  
This site-specificity indicates that cell-surface molecule expression may dictate 
homing patterns of memory cells. Several studies have shown that specific combinations of 
adhesion molecules and chemokine receptors are associated with T cell migration to distinct 
peripheral tissues such as the skin, gut, lungs and even the central nervous system 
(348,462-465). The importance of integrin signaling for lung homing was demonstrated by 
Ray et al. (2004) in which antibody blocking or genetic deficiency of the integrin important 
for lung homing increased memory cell numbers in the spleen but decreased numbers in the 
lung, thereby increasing susceptibility to secondary influenza infection (466). We observed a 
similar situation in the obese mice in which TEM populations were significantly reduced in the 
lungs whereas TCM cells were significantly increased in the spleen. Therefore, maintenance 
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signals as well as homing signals for memory T cells may be impaired in obese mice and 
these studies require further investigation. Studies focusing on adhesion molecule 
expression and cell migration in DIO mice would help to determine the impact of obesity on 
T cell recruitment to the lungs during a viral infection. 
 
E.3. T cell metabolism 
 
 Proliferation of mammalian cells, including T cells, is controlled by extrinsic signals 
which regulate nutrient utilization (467). Non-proliferating, quiescent T cells (naïve and 
memory T cells) use catabolic metabolism to fuel ATP generation (468). Following antigenic 
stimulation and costimulation, T  cells go through a metabolic switch to glycolysis and 
anabolic metabolism, which is required to support their proliferation and effector functions 
(469,470). This switch is achieved by the activation of Akt which then promotes the mTOR 
pathway as well as increasing utilization of glucose and amino acids (471-474). Therefore, 
this switching between differing metabolic states is required for effective generation of T cell 
fates. Indeed, the fact that metabolism underlies the functional capacity of a T cell either to 
respond to infection or to remain as a memory cell suggests that alteration of metabolic 
parameters could greatly affect memory T cell fates (333).  
Very recently, mTOR activity has also been associated with generation of memory 
CD8+ T cells. Araki et al. (2009) and Pearce et al. (2009) have shown that blocking mTOR 
function by rapamycin treatment promoted memory generation during both the expansion 
and contraction phases of the T-cell response. Additionally, Pearce et al. (2009) showed 
that the anti-diabetic drug metformin, activated AMPK and enhanced memory T cell 
generation by inhibiting the mTOR pathway (339,475). Interestingly, dietary restriction 
studies which have been shown to promote lifespan in a number of organisms are thought 
to result in reduced mTOR activity (476). While the exact mechanisms of T cell metabolic 
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switching are still under study, it may be interesting to pursue how DIO can alter T cell 
metabolism and subsequent T cell fate. Obesity has been associated with significant 
alterations in insulin and glucose utilization and is a significant risk factor for the 
development of T2DM (411,423,477). Moreover, there have been recent implications that 
overnutrition directly inhibits insulin signaling in muscle at the level of IRS1 through the 
hyperactivation of the mTOR pathway (478). Additionally, leptin signaling also appears to 
alter AMPK/mTOR activation (479,480). If obesity hyperactivates mTOR, memory T cell 
generation may be at a significant disadvantage. Future studies will focus on the alteration 
of metabolism in T cells from DIO mice and the effects on memory T cell generation 
 
E.4. Regulatory T cells in the obesigenic state 
 
Thymus-derived, naturally occurring, regulatory T (Treg) cells are a subset of T 
lymphocytes that constitutes about 5%–10% of peripheral CD4+ T cells. Treg cells 
constitutively express the high-affinity interleukin-2 (IL-2) receptor α chain CD25 and can 
inhibit effector T cell responses in vitro and in vivo. Treg cells express the forkhead family 
transcription factor Foxp3, a key control gene for their development and function. Treg cells 
have been shown to be important for the establishment and maintenance of self-tolerance 
and the prevention of autoimmune and inflammatory diseases (481,482). Treg cells have also 
been implicated in controlling the primary and memory response to viral infection. Suvas et 
al. (2003) found that the magnitude of a CD8+ T cell–mediated immune response to an acute 
viral infection is also subject to control by Treg. Depletion of Treg with specific anti-CD25 
antibody before infection with HSV resulted in enhanced CD8+ T cell response (483). 
Furthermore, responding CD8+ T cells remained activated for a longer period of time, and 
the memory responses of Treg –depleted animals
 were elevated around threefold compared 
to controls. In vitro studies have also shown that Treg can suppress T-cell 
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proliferation/expansion, IFN-γ secretion, and can abrogate inflammatory signals important 
for T cell activation and accumulation (484,485). 
 To date, very little work has been done to observe the effect of diet-induced obesity 
on the Treg population; however, leptin and leptin signaling appears to be very important for 
Treg function. De Rosa et al. (2007) have found that human Treg cells express high amounts 
of both leptin and the leptin receptor and that the leptin pathway can act as a negative 
regulator of proliferation of Treg (74). Indeed, Taleb et al. (2007) found that leptin deficiency 
in ob/ob mice improves the Treg immune response in these animals (486).  These findings 
may partly explain why leptin receptor deficiency can be associated with increased 
susceptibility to infection (165,198,487). It may also be important in DIO since obese 
individuals are suggested to be in a state of leptin resistance. Leptin resistance may 
contribute to increased Treg populations in DIO models and, therefore, decrease the CD8
+ T 
cell response to influenza and the subsequent generation of protective memory. Further 
studies are needed to investigate the association between DIO, Treg cells and development 
of memory T cells in the context of an influenza challenge. 
 
E.5. Epigenetic control of memory T cells 
 
 Lineage fate decisions in T cells requires that a cell transcribes specific sets of genes 
while repressing or silencing others. Most of this gene expression is not controlled by 
permanent alteration of primary genetic information but by changes in epigenetic differences 
in the genes which are expressed (488-490). In eukaryotic cells, production of biologically 
active proteins is under sophisticated regulation at several points such as the initiation of 
transcription. Accessibility to genetic information by the transcription machinery depends on 
the “openness” of the chromatin structure. Modifications of DNA and DNA-binding histone 
molecules result in different chromatin structures. Epigenetic changes in DNA, such as DNA 
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methylation and histone modifications, allow for structural alterations in chromatin 
organization resulting in permissibility of transcription machinery to initiate gene transcription 
(491). Although epigenetic changes are established early during development and 
differentiation, adaptations occur throughout life in response to intrinsic and environmental 
stimuli. For example, DNA demethylation occurs in the IL-2 promoter of T cells within 20 
minutes of stimulation (492). Molecular differentiation processes that induce memory CD8+ T 
cell fate and drive the development of memory CD8+ T cells are poorly understood. 
However, cell fate decisions of T cell lineages are significantly altered in mice unable to 
promote the gene-silencing effect of DNA methylation. These mice have profound changes 
in the susceptibility and resistance to parasitic infections (493,494). Altered CD4+ 
differentiation has also been documented by experiments using an inhibitor of methylation 
and through genetic abrogation of the maintenance methyltransferase, Dnmt1 (495,496). 
 Genetic reduction of methylation ability has been found to decrease memory T cell 
precursor formation and the responsiveness of the resulting memory T cell pool (497). 
Interestingly, diet-induced obesity has been found to alter methylation status in rats (498); 
however, there appear to be few studies observing the effect of dietary treatment on the 
epigenetic modification of immune cells. Further studies need to be conducted observing the 
effects of DIO on epigenetic modification of T cell fate decisions and their potential effects 
on memory cell generation and subsequent function in the context of viral infection.  
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F. Public Health Significance 
The ability to generate functional memory T cells, either during primary infection or 
by vaccination, has proven to be protective against potentially lethal influenza strains 
exhibiting completely different surface antigens (268). The CDC and WHO have declared 
the currently circulating novel H1N1 influenza strain to be pandemic and obesity appears to 
be an independent risk factor for illness severity (205). The present studies provide 
evidence that increased morbidity and mortality during a secondary influenza infection in 
DIO mice is due to impairment in the ability to generate and maintain functional influenza-
specific memory T cells. This finding, if applicable to a human obese population, has 
significant public health implications given the epidemic rates of obesity worldwide, the 
annual incidence of influenza infection and the threat of a global pandemic.  
Overall, decreased numbers of influenza-specific effector memory T cells over time, 
coupled with the decreased functional capability of these cells in the obese individual, 
suggests that obesity presents an even greater risk from infection with a heterologous 
pandemic strain. Obesity has been definitively linked to a number of comorbidities such as 
T2D and cardiovascular disease (10,13,499). In addition, increased adiposity has also been 
linked with several immunomodulatory effects (70,71,500). However, this work, combined 
with our previous studies (199,200), strengthens the association of obesity as an 
independent risk factor for increased morbidity and mortality from influenza virus infection. 
Traditional methods of preventing influenza infection involve the generation of 
antibodies against viral surface proteins using vaccination. While the efficacy of vaccination 
in obese individuals is outside the scope of these studies, there is evidence that vaccination 
may not be as efficacious in obese individuals (187-189). In the context of this study, recent 
interest has focused on the generation of memory T cells using specific vaccination 
strategies (270,296,501). If these vaccine-induced memory cells cannot function in an obese 
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population, then new vaccination strategies may need to be considered in order to protect 
an increasingly obese world population.  
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